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ABSTRACT OF DISSERTATION 
 
 
HUMAN CARDIOVASCULAR RESPONSES 
TO 
ARTIFICIAL GRAVITY TRIANING 
 
 
Human cardiovascular adaptations to microgravity include decreased plasma volume, 
exercise capacity, baroreflex function as well as decreased orthostatic tolerance upon 
return to a gravity environment.  Several countermeasures have been proposed and tested, 
although currently none have been developed to prevent post-spaceflight orthostatic 
intolerance (OI).  Artificial gravity (AG) generated by short-radius centrifugation (SRC) 
has been proposed as a countermeasure to OI as well as other cardiovascular alterations.  
Methods: Fifteen men and fourteen women underwent three weeks of daily (5 days a 
week) exposure to intermittent (1.0 to 2.5 Gz) artificial gravity on a 1.9m human powered 
centrifuge (HPC) at the NASA Ames Research Center.  Half the subjects exercised 
(active) to power the HPC while half rode passively (passive).  A combination head-up 
tilt (HUT) and lower body negative pressure (LBNP) test was used to determine 
orthostatic tolerance before and after training.  Oscillatory LBNP (OLBNP) was used at 
seven frequencies (0.01 to 0.15 Hz) for two minutes each to assess the dynamic responses 
of the cardiovascular system to orthostatic stress, before and after AG training.  Results: 
Training improved overall tolerance in the group of subjects by 13% (p<0.05); men were 
more tolerant than were women (p<0.05); and active subjects were more improved than 
passive subjects (p<0.05).  Mechanisms of improvement appear to be through decreased 
total peripheral resistance (TPR) and increased stroke volume after training, and 
increased responsiveness of TPR to fluid shifts (faster changes in TPR to changes in calf 
circumference [CC] and OLBNP after training).  There was no change in spontaneous 
baroreflex sensitivity (BRS, calculated by sequence method) or number of sequences per 
number of heart beats (NNS), although BRS analysis did indicate that stimulation to the 
cardiac baroreceptors during 1.0 Gz and 2.5 Gz centrifugation was no different than 
supine control and 70º HUT, respectively.  Taken together, these results suggest that AG 
training improved tolerance through training of local mechanisms in the peripheral 
vasculature, or extrinsic control of peripheral vascular resistance, rather than through 
changes of autonomic control of heart rate. 
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 Chapter 1: Introduction 
 
 
 Space, and Earth’s position in the cosmos has always been a topic of interest (and 
dispute) throughout mankind’s history.  In On the Heavens, Aristotle (384-322 B.C.) 
described the earth as being the center of the universe, with all of the other heavenly 
bodies revolving around us in circular orbits (67).  This geocentric theory was modified 
by Ptolemy (87-150 A.D.) and accepted as fact until the early 16th century when Nicolaus 
Copernicus came up with a heliocentric model in which the earth revolves around the sun 
(68).  Nearly 100 years later, Galileo Galilei used telescopes to observe that not all 
celestial bodies revolve around the earth, and he accepted that the geocentric theory could 
not be correct (63).  One of Galileo’s contemporaries, Johannes Kepler corroborated his 
findings, determining that the earth and the other planets revolved around the sun in an 
elliptical orbit.  Despite the overwhelming scientific evidence, this was still an issue of 
much contention.   The dispute was finally laid to rest in 1687 with the publication of Sir 
Isaac Newton’s Philosophiae Naturalis Principia Mathematica, in which he theorized the 
movement of bodies in space, and developed mathematical equations for proof (67).  
After millennia of thinking that the earth was at the center of the galaxy, mankind has 
made giant leaps in its knowledge and understanding of the earth and galaxy. 
 Only half a century ago man developed the technology to finally travel into space.  
Led by the Russian cosmonaut Yuri Gagarian in April of 1961, and followed by 
American Alan Shepard only a month later, humans broke the bonds of Earth and entered 
space for the first time.  Since then, humans have set foot on the moon, lived in space 
stations orbiting the planet and made hundreds of trips into space.  Even more 
astounding, private civilians developed SpaceShipOne in 2004, the first civilian vehicle 
to reach space (35).  With the growing projected number of humans in space (including 
people with varied physiological makeup and fitness), and the desire to explore farther 
away from Earth, the issue of human safety and space travel needs continued 
investigation.  
 While some dangers of space travel are obvious--space radiation, extreme 
temperatures and vacuum, lift-off, re-entry and landing, to name a few (109, 149); there 
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 are a host of physiological adaptations that the body undergoes in a microgravity 
environment that are potentially harmful.  Exposure to microgravity can cause muscle 
atrophy (36, 80, 87, 123), bone demineralization (69, 70, 80, 137) (kidney stones due to 
high calcium filtration secondary to demineralization), decreased immune function (6, 17, 
109, 113), neurovestibular defects (85, 100, 130) and impaired cardiovascular function 
(7, 10, 21, 37, 40, 46-48, 62, 90, 92, 104, 109, 131, 137, 142, 149); i.e., decreased plasma 
volume and red cell count, decreased autonomic function, cardiac arrhythmias and 
decreased orthostatic tolerance upon return to a gravity environment.  These 
physiological adaptations can decrease astronaut work performance and efficiency as 
well as endanger crew safety.  Some countermeasures have been developed to, if not 
prevent, at least to ameliorate several of these microgravity-induced impairments.  For 
example, exercise is used to maintain work capacity, and especially when combined with 
lower body negative pressure, mitigate muscle atrophy and bone loss (22, 33, 97).  
Ingestion of salt tablets and fluid retaining drugs such as fludrocortisone have been used 
to restore plasma volume (110, 125) before re-entry.  Pressurized G-suits are routinely 
used to help maintain orthostatic tolerance upon landing, but this benefit goes away once 
the astronaut takes the suit off.  As yet there is no operationally-accepted countermeasure 
to prevent the orthostatic intolerance and many other physiological changes associated 
with spaceflight deconditioning. 
Objective 
  
There has been discussion that some form of artificial gravity would help to 
prevent many of the detrimental effects of spaceflight (11, 13, 14, 16, 34, 76, 79, 83, 84, 
128, 145, 146).  The use of a short radius centrifuge (radius of approximately body 
length) to produce centripetal forces along the spinal axis is of growing interest to NASA.   
The purpose of the research described in this document is to determine if artificial gravity 
generated by a short-radius centrifuge (SRC) affects cardiovascular function of normal, 
ambulatory human subjects.  To this extent, measurements were made of the static 
orthostatic responses (to a combination of head-up tilt and lower body negative pressure) 
as well as dynamic responses (to 7 different lower body negative pressure input 
frequencies ranging from 0.01 Hz to 0.15 Hz) in 15 men and 14 women before and after 
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 3 weeks of daily, intermittent exposure to artificial gravity via short-radius centrifugation.  
The hypothesis for this study is that 3 weeks of training will improve orthostatic 
tolerance.  The primary goal of this research is to determine the mechanisms associated 
with the hypothesized improvement. 
 3
 Chapter 2: Background 
Physiological Responses to Orthostatic Stress 
  
Standing up from a supine position in a gravity field (i.e. on earth) imposes a 
substantial challenge to the human cardiovascular system.  Due to the increase in 
hydrostatic pressure gradient acting along the length of the body, venous volume 
increases by approximately 500 mL (105).  This redistribution of fluid from the central 
circulation is immediately detected by baroreceptors (pressure) and, in time, by volume 
(osmolarity) receptors activating reflex responses to increase heart rate, contractility and 
vascular resistance as well as to maintain blood volume.  This response is described in 
detail below. 
The carotid, aortic and cardiopulmonary baroreceptors are sensitive stretch 
receptors, which can detect increases or decreases in arterial pressure.  The afferent fibers 
from carotid baroreceptors transmit signals to the nucleus tractus solitarius (NTS) via the 
glossopharyngeal nerve, while afferents from the aortic arch and pulmonary system 
transmit through the Xth cranial nerve, the vagus (89).  Most cardiac afferents synapse at 
the NTS, where information is assimilated and parasympathetic outflow is relayed to the 
nucleus ambiguus (NA, location of vagal motor neurons) and sympathetic outflow is 
relayed to the caudal ventrolateral medulla (CVLM).  Sympathetic neurons in the spinal 
cord are tonically excited by input from the rostral ventrolateral medulla (RVLM).  In 
turn, RVLM outflow is mediated by the CVLM via the inhibitory neurotransmitter γ-
aminobutyric acid (GABA) (89).   Depending on the afferent input to the NTS, 
sympathetic outflow from the RVLM can be modulated through the CVLM, and there is 
evidence of a direct inhibitory pathway to the spinal motor neurons through the raphe 
nuclei (89). 
At the level of the heart, the right vagus synapses at the sinoatrial (SA) node, 
which is the pacemaker node.  The left vagus synapses near the atrioventricular (AV) 
node which controls the conduction velocity to the ventricles.  The parasympathetic 
neurotransmitter is acetylcholine (ACh) which binds to muscarinic receptors in these 
pacemaker cells.  Acetylcholine slows heart rate through two G-protein second 
 4
 messenger systems; one is an inhibitory G-protein which reduces the slope of the 
depolarizing current in the pacemaker cells by inhibiting cAMP modulation (via reduced 
adenylate cyclase activity) of depolarizing sodium influx and the second is a stimulatory 
G-protein which hyperpolarizes pacemaker cells by increasing potassium efflux.  Both of 
these result in a reduction of heart rate. 
The pre-ganglionic sympathetic neurons to the heart synapse in the thoracic spinal 
column, T1 to T5 (89).  The post-ganglionic neurons innervate the whole heart (i.e., 
myocardial cells of the ventricles, atria and electrical system) as opposed to the nodal 
innervation of parasympathetic neurons.  Norepinephrine (NOR) is the sympathetic 
neurotransmitter, which binds to β1 receptors in the heart.  Its chronotropic effect is 
opposite to that of ACh in that β1 receptors stimulate adenylate cyclase, which increases 
the conversion of ATP to cAMP, leading to an increase in sodium influx.  This increased 
sodium current increases the slope of the depolarizing current, which increases heart rate.  
Norepinephrine also increases chronotropism through increased AV conduction velocity 
and decreased myocyte action potential duration via early repolarization (89).  
Sympathetic-stimulated increase in cAMP also has an inotropic effect; cAMP 
phosphorylates protein kinase A (PKA), which increases calcium influx into the 
myocytes through calcium channels.  PKA also phosphorylates phospholamban, which 
causes the sarcoplasmic reticulum (SR) to remove free calcium from within the cell 
faster.  Over the course of a few heart beats, this increases SR calcium (mainly due to SR 
storage of extracellular calcium), which leads to stronger contractions.  It is clear that 
sympathetic activity has a longer biochemical second messenger chain to act through, and 
this partially explains why it is slower to respond than the parasympathetic system, which 
can respond within a heart beat (5).  Epinephrine, released from the adrenal medulla, has 
an effect very similar to norepinephrine at the cardiac level. 
At the arteriolar and venule level, sympathetic neural activity controls vascular 
resistance through contraction and relaxation of vascular smooth muscle (VSM) cells.   
The post-ganglionic sympathetic neurotransmitter, norepinephrine, binds to α-
adrenoreceptors on the surface of VSM cells.  These receptors act through two G-proteins 
to cause muscle contraction; 1) directly increasing calcium channel influx of calcium and 
2) activation of phospholipase C which catalyzes the conversion of phosphatidyl inositol 
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 bisphosphate (PIP2) to inositol triphosphate (IP3) and diacyl glycerol (DAG).  IP3 
stimulates the release of calcium from intracellular SR, which along with extracellular 
calcium triggers contraction.  DAG activates protein kinase C which helps to sustain 
longer contractions (89).   
Unlike its action at the heart, epinephrine can have an effect opposite to 
norepinephrine when acting on peripheral blood vessels.  Epinephrine binds to β2 
receptors as well as α-adrenoreceptors in the vasculature.  In areas of high β2 density, 
such as in skeletal muscle and the liver, epinephrine can cause vasodilation (89).  
Vasodilation in VSM is a G-protein coupled process.  β2-adrenoreceptor activation causes 
an adenylate cyclase-mediated conversion of ATP to cAMP, which in turn activates 
protein kinase A.  This phosphorylates the activation of Ca-ATPases in the SR and the 
cell wall, reducing intracellular calcium levels and thereby causing vasodilation.  Other 
vasodilators act through the cAMP pathway, including adenosine, histamine, vasoactive 
intestinal polypeptide (VIP) and calcitonin-gene related peptide (CGRP).  Another 
powerful vasodilator, nitric oxide (NO), acts in a different manner.  Rather than being 
coupled to a G-protein complex, NO diffuses through the VSM membrane and activates 
protein kinase G, which is thought to act in the same fashion as protein kinase A (89).   
Concurrent with the neural response, is the endocrine response.  Sympathetic 
outflow releases epinephrine and norepinephrine from the adrenal medulla gland.  The 
action of these two catecholamines is described above.  Renal sympathetic nerve activity 
stimulates the release of renin which converts angiotensinogen to angiotensin I.  
Angiotensin I is eventually converted to Angiotensin II (AII) in the lungs.  Angiotensin II 
plays two key roles in cardiovascular control; it is a potent vasoconstrictor, and it 
stimulates aldosterone secretion, which stimulates sodium and water retention in the 
kidneys.   
In addition to stimulating the baroreceptor response, standing can eventually 
trigger osmolarity receptors, located in the hypothalamus, which mediate the release of 
vasopressin.  Vasopressin, also known as anti-diuretic hormone, stimulates the kidneys to 
retain water.  Vasopressin can also act as a vasoconstrictor in most tissues, except for the 
cerebral and coronary vessels where it actually has a vasodilatory effect (89).  This is an 
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 appropriate response, as it redistributes blood to the heart and brain in cases of 
hypovolemia.   
Considering again a person standing in a gravity environment, a decrease in blood 
pressure is countered by parasympathetic withdrawal and sympathetic activation.  Reflex 
activity then leads to a faster and stronger heart beat, coupled with an increase in vascular 
(in both arterioles and venules) resistance, and hormonal activation to maintain plasma 
volume.  This total reflex helps to maintain perfusion to the brain.  It is important to note 
that the most important regulator of blood pressure is the vascular resistance response 
(105).  Increasing vascular resistance results in decreased filtration at the capillary level 
which can lead to increased venous return to the heart.  If vascular resistance did not 
increase, increasing heart rate would not increase cardiac output as stroke volume would 
continue to fall due to the lack of filling pressure. 
In humans, the splanchnic region is the most compliant, and therefore capable of 
retaining the largest amount of blood volume.  The greatest percentage of total body fluid 
conductance is in the splanchnic region (25%) with the renal system and skeletal muscle 
each containing about 20% of the total conductance (105).  It is these regions, therefore, 
that vasoconstrictor activity is most important in order to shift fluid to the upper thorax 
and brain.  In the legs, contraction of muscles upon standing helps to increase venous 
return by compressing the veins; one way valves in the veins allow blood to travel in one 
direction only—towards the heart. 
In summary, the reflex response to standing in a 1 Gz environment is increasing 
heart rate and cardiac contractility, vascular resistance and blood volume, all in an 
attempt to maintain cerebral perfusion.  If cerebral perfusion is compromised, as is often 
the case in astronauts returning from space, syncope, or fainting, can occur.   
Cardiovascular Deconditioning in Microgravity 
  
 Due to the limited nature of data from actual spaceflights, there are some 
conflicting theories on the exact mechanisms of cardiovascular adaptation to 
microgravity.  In general, the absence of Earth’s gravity gradient shifts fluid from the 
peripheral vasculature to the upper thorax (19, 24, 64, 96, 122).  One would expect 
volume contraction via diuresis, but reduced fluid ingestion, and in some cases, emesis 
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 from space motion sickness, are major contributors to reduced volume (134).  Loss of 
total fluid volume, as well as interstitial filtration (131), causes plasma volume 
contraction and lowering of central venous pressure (21, 30, 31). 
This loss of plasma volume is associated with a 10 – 20% decrease in stroke 
volume (134), and surprisingly, a decrease in resting heart rate (48, 62) which appears to 
be vagally dominated (62).  The decrease in heart rate is surprising, especially in light of 
increased total sympathetic outflow (40) which increases calf vascular resistance(133) 
and in the long term, a reduction in leg volume (96, 122).  Another cause for reduction in 
leg volume is muscle atrophy (36, 86, 123), which is thought to increase overall leg 
compliance, a key player in post-spaceflight hypotension (134).  The next section 
describes in detail the altered physiological response to orthostatic stress after extended 
exposure to microgravity.  
Physiological Responses to Standing after Deconditioning 
 
 Due to the adaptations to microgravity, many astronauts develop presyncopal 
symptoms upon returning to Earth.  The deleterious effects of spaceflight on orthostatic 
tolerance depend on the duration of microgravity exposure and the type of orthostatic test 
used.  Buckey et al. reported 9 out of 14 astronauts were unable to withstand a 10 minute 
stand test after 9-14 days in space (7).  Meck et al. reported that 4 of 5 astronauts become 
syncopal after long duration spaceflight (129 – 190 days) while only 1 out of these same 
5 became syncopal during a short duration spaceflight (91); both tests were 10 minute 
stand tests.  In two separate studies, Meck et al. report post-flight orthostatic intolerance 
to the 10 minute stand test in 4 out of 16 and 10 out of 23 astronauts (47, 92).  Levine et 
al. studied 6 astronauts after 16 days in space, and reported no cases of syncope; 
however, it is important to note that they used a 60º passive head-up tilt with one leg 
bearing the full load of a subject’s weight (the second leg was elevated for 
microneurography measurements), which could stimulate a stronger reflex response than 
passive stand tests, in which astronauts are instructed to relax leg muscles (90). 
 In all cases, post-flight orthostatic testing is characterized by a greater increase in 
heart rate and decrease in stroke volume (7, 47, 90-92, 142).  Although heart rate is 
elevated after spaceflight, there is evidence that this baroreflex mediated response is 
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 altered adversely by spaceflight (7, 46, 48).  At the same time, however, sympathetic 
outflow is intact and responds appropriately (40, 50, 90, 142) to the orthostatic stress.  
Even though sympathetic outflow is intact, it is possible that it is not sufficient to 
maintain peripheral vascular resistance.  There is evidence of increased norepinephrine 
release without concomitant increase in vascular tone (142) suggesting a decrease in α-
adrenoreceptor (92, 142) or increased β-adrenoreceptor responsiveness (104). 
 Vascular resistance has been determined to be one of the key factors in 
distinguishing “finishers” (those able to withstand the 10 minute stand test) from “non-
finishers” (those unable to withstand the 10 minute stand test).  Several researchers have 
noted that “finishers” tend to have higher total peripheral resistance than “non-finishers” 
(7, 91, 92, 136) during the stand test after spaceflight.  Moreover, recent research shows 
that application of midodrine, an α1 agonist, increased vascular resistance and improved 
orthostatic tolerance in a previously orthostatically-intolerant astronaut — lending 
strength to the role of vascular resistance in maintaining orthostatic tolerance after 
spaceflight (101).  
Gender Differences in Physiological Responses to Orthostatic Stress 
 
 There are several well documented differences between male and female human 
responses to orthostatic stress, most notably that men are more tolerant than women (23, 
43, 49, 93, 136, 139).  There are contributing factors to the female predilection to faint 
that have been documented, both in baseline control values and in the response to 
orthostatic stress (i.e. lower body negative pressure, head-up tilt or stand test).  Men tend 
to have higher resting blood pressure (49, 54, 55, 93, 95, 112, 136) as well as increased 
pressure in response to orthostatic stress (23, 55, 111, 136); women tend to have higher 
resting heart rate (93, 95, 112, 136) and increased heart rate response to orthostatic stress 
(45, 93, 111).  While baseline levels of vascular resistance appear to be the same, several 
reports indicated that men have a higher vasoconstrictive response to hypotensive 
challenges than do women (45, 55, 93, 136) while others report no differences in the 
vasoconstrictive response between genders (23, 49, 111).   
Reports of increased norepinephrine levels during hypotensive stress would 
support the idea of increased vasoconstrictor response in men (23, 136) while still others 
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 report no gender differences in circulating norepinephrine levels during orthostatic stress 
(49, 53).  However, there is some evidence for differences in the vascular responsiveness 
to circulating levels of catecholamines.  One report indicates strong vasoconstrictive 
responses to α-adrenergic agonists phenylephrine and clonidine in men, while showing 
no response in women (44).  The same report shows that men also have greater 
responsiveness than women to the β-adrenergic agonist isoproterenol.  One of the 
contributing factors to decreased orthostatic tolerance in females is probably their 
hypoadrenergic response to stress (44, 92, 136), which may be confounded by the 
vasodilatory effect of circulating estrogen (129, 143, 144).  Additionally, women tend to 
pool more blood in the splanchnic area, which could also adversely affect orthostatic 
tolerance (93, 139). 
Previous Countermeasures 
 
 One of the most dangerous effects of cardiovascular deconditioning, especially in 
the context of space shuttle landing or emergency egress in a gravity environment, is 
orthostatic intolerance.  There have been several countermeasures developed that have 
attempted to prevent this.  One successful countermeasure is the use of G-suits, which 
work by applying positive pressure to the legs and lower thorax, thereby aiding in venous 
return and maintaining cerebral perfusion (32).  However, these effects are only transient, 
and disappear once the G-suit is removed after landing. 
 One of the underlying reasons for post-flight orthostatic intolerance is 
hypovolemia, and various attempts have been made to restore plasma volume.  Ingestion 
of salt water (8 grams of NaCl with 960 mL of water) before re-entry has been shown to 
restore plasma volume and prevent orthostatic hypotension in a flight of less than 7 days 
(9).  However, the benefits of saline loading disappear during long flights (141).  There 
have been mixed results to saline loading in simulated microgravity (6º head-down bed 
rest) studies.  Using the same protocol that U.S. astronauts use (8, 1 gram NaCl tables in 
960 mL of water), Vernikos et al determined that this method was insufficient to restore 
plasma volume (and orthostatic tolerance) to pre-bed rest levels (125).  However, by 
basing saline ingestion on body weight instead of limiting it to the standard 960 mL, 
Waters et al were able to restore plasma volume and prevent orthostatic intolerance in a 
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 similar simulated microgravity study (135).  It is important to note that, even though 
studies in simulated microgravity are many times similar to actual results from a 
microgravity environment, results are not always similar.  The use of fludrocortisone has 
been shown to prevent plasma volume loss (and hence maintain orthostatic tolerance) in a 
simulated microgravity study (125), but the same protocol used in an actual spaceflight 
environment did not improve orthostatic intolerance (110).   
It is likely that plasma volume restoration alone is not sufficient to prevent 
spaceflight-induced orthostatic intolerance; some form of stimulation or stress to the 
cardiovascular system is likely needed to attenuate deconditioning in microgravity.  
Lower body negative pressure (LBNP) has been proposed as a means of generating a 
head-to-foot force (65) and is well known for displacing fluid to the lower body and 
thereby stimulating the cardiovascular system (25, 60, 61, 65).  Application of LBNP has 
been shown to be effective in spaceflight and ground based studies to prevent orthostatic 
hypotension (3, 42, 59-61, 71, 119).  However, the duration and frequency of required 
LBNP stimulation makes it unattractive during spaceflight, where time is already limited 
(20, 84). 
Another countermeasure that is currently being used, but it not completely 
effective in preventing post-flight hypotension, is aerobic exercise (15, 22, 33, 58, 107).  
Astronauts exercise either on a stationary bicycle or treadmill, and can perform isokinetic 
training with spring resistance devices (33).  This method of moderate intensity exercise 
for long durations is effective in maintaining work capacity, but not in maintaining 
orthostatic tolerance.  When studied in ground based simulations of microgravity, an 
acute bout of maximal exercise one day before the end of the study was shown to be 
effective in restoring plasma volume and orthostatic tolerance to pre-bed rest levels (27, 
29, 33, 38, 39).  Although this countermeasure did not elucidate greater tolerance than 
control subjects after spaceflight, it did increase cardiac output and stroke volume, and 
shows merit for future use (94). 
Perhaps the most logical countermeasure to deconditioning in a microgravity 
environment is to use an artificial gravity source to stimulate the cardiovascular system.  
Based largely on the relatively small payload capabilities of current space transports, a 
short radius, or short arm centrifuge (SRC) has been suggested to provide artificial 
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 gravity in space (11, 12, 14, 66, 75, 76, 132, 145).  The idea of short arm centrifugation is 
not a new one; in 1966, White et al showed that periodic centrifugation from 1 Gz to 4 Gz 
for 20 minutes a day, 4 times a day during 41 days of bed rest prevented the expected 
orthostatic intolerance after bed rest (140).  In the same year, Piemme et al determined 
that human tolerance on a 4 foot, 9 inch centrifuge ranged from a couple hours at 4 Gz to 
several minutes at 7 Gz (99). 
One of the unknowns in the field of SRC research is the amount of centrifugation, 
both duration and magnitude, needed to prevent the detrimental effects of microgravity.  
Hastreiter and Young determined that 1.5 Gz (at the feet) was required to simulate calf 
blood flow changes similar to standing (66).  In a head-down bed rest study, 2 hours a 
day of passive standing was sufficient to prevent post-bed rest hypotension, although 4 
hours a day of passive standing was required to maintain plasma volume (124).  Two 
hours of standing also prevented simulated microgravity effects in a rat tail-suspension 
study (147).  In another non-human study, Korolkov et al studied primates during 4 
weeks of HDBR (83).  They determined that short radius centrifugation was successful in 
preventing extracellular fluid loss and orthostatic hypotension resulting from bed-rest.  
More interestingly, they determined that 1.2 Gz, 3 times a week may be more effective 
than higher Gz levels, 4 to 5 times a week (83).   
In a simulated microgravity study, Iwasaki et al determined that 1 hour of 
exposure to 2 Gz on an SRC was sufficient to prevent the negative effects of 6º head 
down bed rest (HDBR) on baroreflex function and plasma volume, although this 
countermeasure alone was not sufficient to maintain exercise capacity (75); however, 
another study showed that combining acceleration with moderate exercise helped to 
maintain upright exercise responses (79).  Furthermore, Vil-Viliams showed that exercise 
combined with centrifugation at 0.8, 1.2 and 1.6 Gz was effective in maintaining 
orthostatic tolerance from 3 to 28 days of head out water immersion (127).  
It is generally accepted that some form of artificial gravity will be effective in 
ameliorating many of the detrimental effects of spaceflight, not only on the 
cardiovascular system, but most physiological systems.  Current research goals are to 
determine what kind of artificial gravity is necessary; how much is sufficient, and for 
how long?  
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 Research by Our Laboratory 
  
Based on the current knowledge presented in the literature, our laboratory 
recognized the advantage of short radius centrifugation as a countermeasure to 
spaceflight deconditioning.  We therefore participated in a study that used a 1.9 meter 
SRC to document the effects of 3 weeks of acceleration training with, and without, 
exercise on the cardiovascular response to one hour of 70º head-up tilt (HUT) on normal, 
ambulatory male volunteers (57, 118).  We determined that intermittent acceleration (7 
cycles of 2 minutes at 1 Gz followed by 2 minutes at 2.5 Gz) for 3 weeks improved 
orthostatic tolerance and baroreflex activity (118), both of which are known to be 
attenuated after spaceflight (46) and bed rest (75).   
 
Rationale 
 
One of the shortcomings of the above study was that a one hour time limit was 
placed on the orthostatic stress test, and the test was terminated at this point, regardless of 
outcome.  Therefore, we were unable to get an accurate assessment of the effect 
acceleration training had on orthostatic tolerance, as many subjects withstood the hour- 
long HUT both before and after the training protocol.  Secondly, this study was only 
performed on men, and thirdly, only the static responses (to a 70º head-up tilt) of training 
effects on the cardiovascular system were assessed. 
The purpose of the present study was to determine cardiovascular responses of 
ambulatory humans to 3 weeks of intermittent acceleration training (described above) 
with and without exercise.  More specifically, lower body negative pressure was coupled 
with head-up tilt to bring all subjects to a pre-syncopal endpoint, in order to determine an 
accurate assessment of artificial gravity training (with and without exercise) on 
orthostatic stress tolerance time.  Secondly, oscillatory lower body negative pressure was 
used at 7 different frequencies from 0.01 to 0.15 Hz, to assess the dynamic response of 
the cardiovascular system before and after artificial gravity training.  Thirdly, 15 men and 
14 women were studied in order to elucidate any gender differences in these 
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 cardiovascular responses before and after artificial gravity training. Specifically the 
present study was designed to discriminate interactions between before/after training, 
men/women and exercise/non-exercise effects of artificial gravity training.  
 14
 Chapter 3: Methods 
Subjects 
 
Twenty-nine volunteers began this study, 15 male and 14 female.  One male 
subject was removed from the study for failing to comply with study regulations, and one 
female subject voluntarily withdrew herself.  Data from a second female subject was 
discarded because of excessive pre-ventricular contractions when studied.  Results are 
reported for data from a total of 26 subjects, 14 male and 12 female.   
All subjects were normal, healthy volunteers and were screened for 
cardiovascular health and absence of drug and alcohol use (including tobacco).  Men 
were 32.4 ± 2.6 years old, 180.4 ± 1.4 cm tall and weighed 81.2 ± 2.0 kg.  Women were 
31.7 ± 1.8 years old, 164.7 ± 4.12 cm tall and weighed 61.45 ± 19.3 kg.  Male subjects 
were randomly assigned to either the active (those who exercised while on the centrifuge) 
or passive (those who rode passively) group.  Female subjects were also randomly 
assigned to either group, but an effort was made to pair active and passive subjects based 
on their menstrual cycles.  Complete anthropomorphic data for all subjects can be found 
in Table 1 of the Appendix. 
Training Protocol 
 
Artificial gravity training of subjects occurred on the NASA Ames Human 
Powered Centrifuge (HPC) in building 221A at the Ames Research Center, Moffett Field, 
California.  Subjects trained 5 days a week (Monday thru Friday), for 3 weeks.  Subjects 
were assigned the same time slot everyday, for consistency in training.  Experiments with 
male subjects took place in April/May of 2003, while female subjects were studied in 
January/February of 2004.  An early schematic of the HPC is shown in Figure 3.1.  Since 
the time of this drawing, one of the second seats was modified for a passive rider 
(ergometer removed and plate fabricated for resting feet, changes can be seen in the 
photograph in Figure 3.2). 
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Figure 0.1: Schematic of the human powered centrifuge at the NASA Ames Research Center. 
 
During the week before training began, each subject was introduced to the 
centrifuge facility.  They were allowed to ride the HPC at moderate speeds in order to 
feel comfortable with the apparatus.  They were then shown the tilt table and all of the 
corresponding instrumentation.  Each subject was placed on the table and experienced 
several tilts and lower body suctions before the study started. 
 When subjects arrived for a training run, 3 ECG electrodes (3M Red Dot™) were 
placed on their thorax; one on the left abdomen and two on the upper chest, left and right.  
ECG was acquired with the Pilot (COLIN Medial).  This device can also be used to 
acquire non-invasive, continuous, tonometric blood pressure, but is very sensitive to 
motion artifact.  Therefore, the active rider was instrumented for continuous blood 
pressure and heart rate (calculated from the blood pressure waveform) measurements via 
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 a plethysmographic device, which is more tolerant of motion artifact (Portapres, TNO).  
The finger cuff for the Portapres was placed on one of the fingers of the left hand, 
between the 1st and 2nd knuckles.   
Because the passive riders were able to lie still during the training sessions, blood 
pressure was acquired with the Pilot.  The passive rider’s left hand was placed in a wrist 
brace designed to flex the wrist in order to expose the radial artery.  The tonometric 
sensor was then placed approximately over the artery in order for the instrument to make 
autonomic adjustments to obtain optimal signals. Acceptable signals were then verified 
by the experimenter on both subjects.  Analog outputs were passed through slip rings and 
digitized through a National Instruments board at 200 Hz.  Data acquisition was 
controlled by a program written by NASA Ames personnel in Labview on a Pentium III 
class computer. 
 Based on subject’s heights, the seats were placed in such a fashion that the active 
rider could pedal comfortable, and the passive rider could easily rest his feet flat against 
the rest plate.  Both subjects had their legs bent and thighs elevated, Figure 3.2.  
Sandbags of various weights were also used to balance out any difference in subject 
weight.  Blindfolds and headsets were secured on the subject’s heads and an alarm switch 
was placed in their right hands to alert investigators in the event of an emergency.  
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Figure 0.2: Photograph of 2 subjects prior to a training session.  Active subject on the left, passive 
subject on the right.  Personal photo taken with consent from subjects. 
 
 For each training run, blood pressure, heart rate and ECG signals were verified 
and alarm switches and headset communications (brand of head set?) tested for correct 
operation.  The active rider was then instructed to begin pedaling up to a rate of 22 
rotations per minute to reach the 1 Gz level at the outer edge of the centrifuge.  After 
seven minutes of 1 Gz, the active rider was then instructed to increase the rate of rotation 
to 35 rpm (which is equivalent to 2.5 Gz) in ten seconds.  After two minutes at 2.5 Gz, the 
active rider was instructed to pedal backwards as the centrifuge slowed down to 1 Gz.  
Once the centrifuge reached 1 Gz, the active rider maintained the rate of rotation for 
another 2 minute period.  This cycle of 2 minutes at 2.5 Gz and 2 minutes at 1 Gz was 
repeated 6 times for a total of 7 periods.  If at any time the active subject was unable to 
maintain the correct Gz level, an off-board operator assisted him/her.  A typical 
acceleration profile with corresponding heart rate and blood pressure values can be seen 
in Figure 3.3.   
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Figure 0.3: Typical AP and HR response of an active (blue) and passive (red) subject during a 
normal training session. 
 
 During these training sessions, communication was maintained between the 
subjects and the person monitoring their vital signs (blood pressure and heart rate) to 
insure subject safety.  If the active subject’s heart rate ever reached 90% of his/her age 
adjusted maximum heart rate (220 – age), then the off-board operator was asked to help 
pedal.  In the case of the men, this happened only rarely, and only during the first couple 
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 days of training.  In the case of the women, this happened quite frequently—especially 
during the transitions from 1.0 to 2.5 Gz. 
 After each training session, each subject was de-instrumented and went about 
their normal daily activities.  Subjects were asked to not participate in any vigorous 
athletic training, although they were encouraged to maintain their already light to 
moderate exercise lifestyles. 
Head-Up Tilt / Lower Body Negative Pressure (HUT/LBNP) Test 
 
In order to assess the efficacy of this training protocol, each subject’s response to 
orthostatic stress was tested within 2 days before, and within 2 days after this 3 week 
training period.  Our provocative test was a combination of 70º head-up tilt with lower 
body negative pressure (HUT/LBNP).  Head-up tilt is a classic orthostatic stimulus, but 
in healthy individuals it may take several hours for pre-syncopal symptoms to occur.  By 
adding LBNP (protocol discussed below) to this stimulus, we were usually able to reach a 
pre-syncopal endpoint within 20 minutes.  Care was taken to test each subject at the same 
time of day both before and after training.  Ambient air temperature was also controlled 
to be the same for both tilts (71 ºF ± 2ºF). 
 Each subject arrived 30 minutes before their scheduled test time in order to place 
ECG electrodes, intravenous catheter (Quick-Cath, Baxter) and consult with the medical 
monitor before tilting.  Once on the table, the subjects were tilted to supine, then to 70° 
head-up in order to verify seat comfort.  The subjects adjusted as necessary, and when 
they were comfortable, they were returned to the supine position.  A mercury strain gauge 
(EC-4, Hokansen) was then placed around the subject’s left calf to measure changes in 
calf size.  Their left leg was supported by foam blocks under the ankle and thigh to 
prevent any motion artifact in calf circumference measurements.  At his time in the 
procedure, the LBNP chamber was placed around the subject lower body, below the iliac 
crest.  Subjects were then further instrumented.  Continuous blood pressure was measured 
using a Finapres (Ohmeda) device on one of the three middle fingers of the left hand 
(generally the ring finger).  Laser doppler probes (PF4001, Perimed) were placed on the 
left palm and forearm for skin perfusion, concentration of moving blood cells, and 
velocity of blood cells.  An arm cuff automated blood pressure measurement system 
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 (UA767, AND Medical) was placed on the upper left arm over the brachial artery for 
verifying the accuracy of continuous blood pressure measurements made by the Finapres.  
The subjects left arm was extended out from the body and rested in a plastic tray as 
shown in Figure 3.4.  The left arm was positioned in such a fashion that the finger cuff 
sensor was at the same hydrostatic level as the heart in both supine and 70º head-up 
positions.  If necessary, a heating pad was placed on the left arm to keep the fingers warm 
in order to obtain optimal blood pressure signals from the Finapres. 
 
 
Figure 0.4: Fully instrumented subject on tilt table prior to HUT/LBNP test.  Personal photo taken 
with subject's written consent. 
 
Leads were attached to the 11 ECG electrodes for thoracic impedance 
measurements (BoMed, Cardiodynamics).  Subject’s height and weight were entered into 
the BoMed computer for calculation of stroke volume, cardiac output and end diastolic 
volume, and all signals for verified for quality. 
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 At this point, an 800cc spirobag was used to calibrate fluctuations in thoracic 
impedance associated with breathing.  The subject’s nose was clamped, and the subject 
was instructed to take 5 even expirations and inhalations into and from the 800cc 
spirobag.  The brachial arterial pressure was taken from the AND device and the CC was 
balanced to zero before beginning the control period.  At this point in the instrumentation 
period, the subject has been supine on the table for 20 to 30 minutes.  
The room was kept quiet, and the subject was asked to remain still and quiet for 
the entire duration of the study, unless they felt any discomfort or pre-syncopal 
symptoms.  Ten minutes of supine control data were collected.  At the end of the 10 
minute control period, 23 cc’s of blood were drawn (Blood Draw #1) from the 
intravenous catheter and the brachial cuff blood pressure was acquired.  The calf 
circumference was again balanced, and the subject was tilted to 70° head-up.  After five 
minutes at 70°, the vacuum pumps were turned on and -20 mmHg of vacuum was applied 
to the LBNP chamber.  This was held for 3 minutes, at which point the vacuum was 
increased to -30 mmHg.  Twenty-three cc’s of blood were drawn (Blood Draw #2) at the 
beginning of the -30 mmHg LBNP level.  Vacuum was held for 3 minutes again, at which 
time it was increased another 10 mmHg.  This procedure was repeated up to -90 mmHg, 
or until pre-syncopal conditions developed. 
Once pre-syncopal symptoms developed, the vacuum was shut off and the table 
was brought back to the supine position.  Blood draw #3 occurred at 1 minute and 30 
seconds after the tilt table was brought down from the 70° head-up position.  If any of the 
subjects had difficulty recovering from the stress-induced pooling, they were brought to a 
slight head-down position to facilitate venous return.  If the subject developed pre-
syncopal symptoms before the -30 mmHg LBNP level, blood draw #2 was taken 
immediately after the table was brought down and blood draw #3 occurred immediately 
after blood draw #2 in these cases.  Data during recovery were acquired for 5 minutes 
after the table was brought to the supine position.  At the end of recovery, the medical 
monitor questioned the subject to obtain details about their pre-syncopal symptoms.  Data 
acquisition was set to “standby” and the subject was allowed to recovery from the 
HUT/LBNP test for 15 minutes before the next test (oscillatory lower body negative 
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 pressure, OLBNP, see below).  During this period the Finapres was turned off to reduce 
external pressure to the finger and improve subject comfort.   
 
Oscillatory Lower Body Negative Pressure (OLBNP) Test 
 
 Fifteen minutes after the end of recovery of the HUT/LBNP test, the Finapres was 
turned back on for continuous blood pressure measurement, and a brachial artery pressure 
measurement was recorded via the AND cuff.  The calf circumference gauge was 
balanced again and the subject was exposed to -50 mmHg of sinusoidal lower body 
negative pressure at 7 different frequencies, for 2 minutes each.  The seven frequencies 
were 0.01 Hz, 0.02 Hz, 0.04 Hz, 0.08 Hz, 0.10 Hz, 0.125 Hz and 0.15 Hz.  These seven 
frequencies were randomized for each subject, except for the 0.01 Hz frequency, which 
was always the last frequency.  Because 0.01 Hz is the slowest, and therefore most 
stressful to the body, it came last in the event that the subject developed any pre-syncopal 
symptoms.  However pre-syncopal symptoms never occurred during any frequency of the 
OLBNP test.   
 All data for the HUT/LBNP/OLBNP tests were digitized at 250 Hz on a 16-bit 
analog to digital converter (DI-220 Parallel Port, DATAQ).  Data was recorded on a 
Pentium II class laptop computer. At the end of each subject’s test, data were 
immediately backed up on CD, 100MB Zip disk and 3 different computer hard drives.   
 
Data Analysis 
 
Pre-processing 
 Training data were acquired as binary Labview files and HUT/LBNP/OLBNP 
data was acquired using Windaq Pro acquisition software, also as binary files.  The data 
were the imported in to the following three analysis programs written in visual C++ by 
Dr. David Brown (University of Kentucky, Biomedical Engineering): 
ConvertLabview.exe, ScanDataq and Browser ConvertLabview.exe and ScanDataq.exe 
were used to convert the training and tilt test data, respectively, into a binary data format 
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 recognizable by Browser.    In Browser, heart rate and RR interval were calculated from 
the ECG trace.  Based on the timing of the cardiac cycle from the ECG trace, systolic, 
diastolic and mean (1/3 systolic + 2/3 diastolic) blood pressure were calculated from the 
arterial pressure channel.  These data were then converted to floating point, 32-bit integer 
binary data files for export into Matlab. 
 In Matlab, fread.m and fopen.m subroutines were used to import the data into a 
matrix for further pre-processing.  Once in Matlab, total peripheral resistance was 
calculated as mean arterial pressure divided by cardiac output.  The data were then low-
pass filtered with a finite impulse response filter having a cutoff frequency of 5 Hz.  
Using the filtfilt.m algorithm, these data were passed through the filter forward and 
backward, to minimize any phase distortions.  The data were then down sampled to 10 
Hz to save disk space and increase processing speed. 
 At this point, the data exist in a 21 column matrix with each column consisting of 
a channel of data as shown in Table 2 of the Appendix.  The data were further subdivided 
into segments for supine control, tilt without LBNP, the tilt plus LBNP segments, 
recovery and the seven different OLBNP frequencies.  For control, tilt, tilt plus LBNP 
and recovery, two types of segments were created.  The first type was a raw segment 
consisting of all the data, from the very beginning of each stress level to the very end.  
The second segment type was modified to contain relatively steady-state data.  This 
means that any non-linear trends, such as those seen when subjects experience pre-
syncope, were removed from the “steady-state” segments.  For the OLBNP segments, 
there were also two types of segments; a raw segment consisting of all the data for a 
particular frequency as well as segments of 100 seconds consisting of complete cycles of 
data for the 0.01, 0.02, 0.04, 0.08, 0.10 and 0.15 Hz segments.  For the 0.125 Hz segment, 
96 seconds of data were used so that an even number of complete cycles was available 
for analysis. 
 
Tilt Tolerance 
 Tilt tolerance was assessed via two methods.  The first method was to determine 
the total time the subject was able to withstand HUT plus any combination of LBNP 
before developing pre-syncopal symptoms.  In this case, time from the raw data set, in 
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 seconds, was used for analysis.  However, because the level of vacuum applied during 
LBNP is sometimes slightly variable (+/- mmHg) , and because there are also variations 
(however minute) in the length of time (+/- seconds) at each LBNP level, a stress index 
consisting of a combination of tilt time (in seconds) and LBNP (in mmHg) was also used.  
There is evidence that -50 mmHg of LBNP causes blood pooling similar to 70° head-up 
tilt (132); therefore the tilt channel was assigned a value of -50 mmHg and added to the 
LBNP channel, resulting in a new indicator of orthostatic stress in pressure units.  Using 
this method, the initial LBNP applied to the subjects (-20 mmHg) was then given a value 
approximately equal to 70 mmHg.   
 
Mean Values 
 For each steady-state segment of data, mean values for each channel were 
calculated.  Data were then averaged by gender and training (i.e. active or passive 
subjects) group, both before and after training.  Standard error of the mean was also 
calculated for the same groups.   
 
Spectral Power 
 Spectral power estimations were performed using the power spectral density (psd) 
algorithm in Matlab.  This algorithm utilizes Welch’s averaged periodogram method.  For 
HUT/LBNP data, this method works by taking the first 1024 points of data for each 
variable, removing the mean and any linear trend from this segment and then passing 
these data through a 1024 point Hanning window.  The magnitude of the FFT for this 
segment is calculated and stored.  The program then moves 50% of the segment (512 
points) into the data, and does the same thing to the next 1024 points.  The magnitude-
squared of these two FFT segments are averaged to form the new output.  The algorithm 
continues this process until it reaches the end of the data.  If at any time there are less 
than 1024 points, the data is zero padded to length 1024.  The output of the PSD 
algorithm was then integrated over the low frequency (LF, 0.04 – 0.15 Hz) and high 
frequency (HF, 0.15 – 0.40 Hz) regions. 
 For OLBNP data, first harmonic amplitudes and phases of the fast fourier 
transform (FFT) are reported.  For all frequencies other than 0.125 Hz, complete cycles 
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 could be obtained with 100 second (1000 pt) segments and for 0.125 Hz, 960 points of 
data were used to obtain 8 complete cycles at this frequency.  Phase outputs are reported 
with respect to OLBNP input.  
 
Blood Assays 
 Catecholamine assays were performed in Dr. Michael Ziegler’s lab at the 
University of California, San Diego using a radioeznymatic technique (81).  Other 
vasoactive hormones were analyzed by Dr. Helmut Hinghofer at the University of Graz, 
Austria using commercially available kits. 
 
Baroreflex Analysis 
 Sensitivity of the cardiac baroreflex (BRS) as well as number of cardiac 
barosequences (NNS, normalized by number of heart beats) were assessed using self-
written script files in Matlab.  Baroreflex activity (BA, sensitivity and normalized number 
of sequences) was calculated for all HUT/LBNP segments as well as for data early and 
late in HPC training.  For training data, the BA numbers reported are averaged from two 
days selected within the first four days of training and within the last three days of 
training.  On each day of training, 7 segments at 2.5 Gz and 8 segments at 1.0 Gz are 
analyzed. 
 For each segment of data, the ECG trace is used to calculate beat-to-beat RR 
Interval (RRI) and systolic blood pressure (SBP).  Each SBP sequence is analyzed for a 
sequence of three or more beats increasing or decreasing in succession, with each change 
between beats being 1 mmHg or more.  During these sequences, the RRI is examined (on 
a one beat delayed basis) for changes in the same direction as the SBP changes, with each 
change being 8 ms or more.   Eight ms is chosen because ECG was digitized at 250 Hz, 
so each R-wave can only be resolved within 4 ms.  This leads to a possible 8 ms error 
when comparing 2 beats, hence the 8 ms criteria for changes in RRI.   
 Each barosequence is plotted as RRI vs. SBP, and the slope of the best fit line 
between the points is calculated from Equation 1 below as an index of BRS.  The NNS is 
calculated as the number of barosequences (n) divided by the total number of heart beats 
in each analyzed segment of data. 
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Statistics 
 Four factor analysis of variance (ANOVA) was used to calculate significance 
between all groups using SAS (The SAS Institute) software.  Between group variables 
were gender (male vs. female) and training group (active vs. passive) and within group 
variables were test day (before vs. after training) and stress level (control/tilt/LBNP level 
or in the case of OLBNP, the LBNP input frequency).  Fischer’s least significant 
difference method was used, therefore significance was accepted for p < 0.05.  An 
example of SAS code used is presented in Appendix B. 
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 Chapter 4: Results 
A subject’s typical response to a HUT/LNBP test is shown below in Figure 4.1. 
All other individual responses are shown in Appendix A.   
 
Figure 0.1: Typical AP, HR, SV, CO, TPR and CC responses of a presyncopal subject to 70º HUT 
combined with progressive levels of LBNP. 
 
 At the onset of tilt, the calf circumference starts to rise, indicative of fluid 
accumulating in the lower leg.  In response to this shift of fluid, heart rate and vascular 
resistance increases to maintain venous return and blood pressure.  In the case of this 
subject, this is seen as an increase in blood pressure.  Stroke volume decreases as the 
heart rate increases, as there is less filling time.  These changes continue as lower body 
negative pressure is applied.  This particular subject withstood -60 mmHg of LBNP 
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 before developing classical vasovagal syncope, indicated by decrease in blood pressure, 
heart rate and vascular resistance.   
There were varying degrees of tolerance among the subjects, and only a very few 
were able to endure the stress long enough to make to the higher vacuum levels (-50 and -
60 mmHg).  The only segments that all subjects had in common were the 10 minute 
supine control period and the 5 minute HUT period before any LBNP was applied.  
Although one subject experienced presyncopal symptoms before the vacuum was 
applied, most subjects were able to endure the passive HUT.  After application of LBNP, 
tolerance ranged from a few seconds at the -20 mmHg level to some subjects enduring 
several minutes of -60 mmHg.  Because of this difference in how each subject endured 
LBNP, each subject’s response during the last four minutes (LST4) of stress, regardless 
of LBNP level, was also assessed.  This LST4 value was assessed before presyncopal 
symptoms develop.  For the above reasons data are presented for 5 different experimental 
levels (referred to in the following discussion as “segments”): control, tilt (w/o LBNP), -
20 mmHg LBNP, LST4 and recovery.   
Effects of Artificial Gravity on HUT/LNBP Tolerance  
 Artificial gravity training increased HUT/LNBP tolerance in the group of 26 
subjects by 13% (t-test, p < 0.02, Figure 4.2).  As shown in Figure 4.2 below, men lasted 
longer during the HUT/LNBP test than did women (p < 0.01).  When examined 
separately, the group of active subjects (men and women combined) were improved by 
training (p < 0.05) as were the men (active and passive combined, p < 0.04).  Passive 
women were not improved by training.  When using the “stress index” (Method two) no 
differences were indicated from those already obtained from the standard “time of tilt” 
analysis. 
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Figure 0.2: Tilt tolerance time shown for men (left, 7 active, 7 passive) and women (right, 7 active, 5 
passive), before and after artificial gravity training.  
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 Mean Values for HUT/LNBP Test Before and After AG Training  
 
Arterial Pressure  
Mean values of arterial pressure are shown in Figure 4.3.  When pooling all data 
to make segment-only comparisons, AP was not different from segment to segment (i.e., 
there were no main segment effects in the ANOVA).   
 
 
Figure 0.3: Blood pressure by gender and training group, before and after AG training.  
 
While there was no overall difference in blood pressure during different levels of 
orthostatic stress when pooling both men’s and women’s data, separating gender did 
elucidate some different responses to orthostatic stress.  Compared to supine control, men 
increased AP during HUT and -20 mmHg LBNP while women decreased AP during -20 
mmHg LBNP, Figure 4.4.  Men had higher AP (99.8 ± 1.1 mmHg)  than women (89.7 ± 
1.6 mmHg), Figure 4.4. 
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Figure 0.4: Gender by segment difference in blood pressure.  
 
Artificial gravity training decreased blood pressure in all subjects, Figure 4.5. 
 
 
Figure 0.5: Mean AP (for all segments of the HUT/LNBP test) before and after AG training.  
 
Heart Rate 
In response to increasing orthostatic stress, heart rate increased as would be 
expected.  Heart rate increased from control to HUT, HUT to -20 mmHg LBNP, and -
20mmHg LBNP to LST4 before returning to control levels during recovery, Figure 4.6.  
There was no overall effect of training, although there was a training by segment 
interaction – heart rate was higher during the last 4 minutes of stress after training (98.4 ± 
4.2 bpm before, 104.5 ± 3.3 bpm after training).   
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Figure 0.6: Heart rate by gender and training group, before and after AG training. 
 
Regardless of test day (i.e. regardless of before or after training), women had higher HR 
during -20 mmHg LBNP than did men, Figure 4.7. 
 
Figure 0.7: Gender by segment difference in heart rate.  *Significant difference between gender. 
 
Stroke Volume 
Mean stroke volume decreased with HUT and -20 mmHg LBNP.  Statistically, 
the mean value of SV during LST4 was not different from -20 mmHg LBNP, although it 
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 was significantly lower than control and recovery.  The recovery value of SV was higher 
than the control value, Figure 4.8.   
 
Figure 0.8: Stroke volume by gender and training group, before and after AG training. 
 
Men had a higher stroke volume than did women (Figure 4.9a) and training increased 
overall stroke volume (Figure 4.9b). 
 
Figure 0.9: (a) Gender difference in stroke volume, (b) AG training effect on stroke volume. 
 
Cardiac Output 
Cardiac output initially decreased with the onset of HUT, but then was maintained 
as the test progressed, reaching control values again during supine recovery, Figure 4.10.   
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Figure 0.10: Cardiac output by gender and training group, before and after AG training. 
 
Men appear to have had a higher cardiac output than women (Figure 4.11a) but this was 
only at a marginally significant level (p = 0.068).  When examined as a function of test 
day, men had a higher cardiac output after training than before training, and this after 
training value was higher than women’s CO on both experimental days (Figure 4.11b).  
 
Figure 0.11: (a) Gender difference in cardiac output, (b) gender by test day effect on cardiac output.   
 
End Diastolic Volume 
Similar to stroke volume, end diastolic volume decreased at the onset of tilt, and 
continued to decrease with the onset of LBNP.  Also similar to stroke volume, the LST4 
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 value was not different from the -20 mmHg LBNP value and the EDV recovered to a 
level higher than control, Figure 4.12. 
 
Figure 0.12: End diastolic volume by gender and training group, before and after AG training. 
 
Men had higher EDV than women (Figure 4.13a).  There was not a main training effect 
in the ANOVA, but there was a training-induced increase in EDV during control and 
recovery (Figure 4.13b). 
 
 
*
*
Figure 0.13: (a) Gender difference in EDV, (2) day by segment effect on EDV.  *Significant effect of 
training. 
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 Total Peripheral Resistance 
Total peripheral resistance increased in response to HUT (Figure 4.14).  TPR was 
maintained when LBNP was started, but was significantly lower than the HUT value 
during the last 4 minutes of stress.  TPR recovered to the control value during recovery.   
 
Figure 0.14: TPR means by stress level.  
 
Figure 0.15: Total peripheral resistance by gender and training group, before and after AG training.  
 
ANOVA results indicate that artificial gravity training decreased TPR, but this can be 
misleading, as Figure 4.15 (above) shows that TPR isn’t increased in active women after 
training.  This was corroborated by a protocol by gender interaction effect, indicating that 
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 training decreased TPR in active men, passive men and women, but not in active women.  
Notice, however, that active women have a lower TPR before any artificial gravity 
training, and their before/after values look similar to the after values of the other 3 
groups. 
 
Calf Circumference 
Due to the time-dependant nature of calf circumference during an orthostatic 
stress, absolute values of CC had to be normalized by time of stress, Figure 4.16.   
 
Figure 0.16: Various calf circumference slopes measured. 
 
CCI refers to the initial slope at the onset of tilt, from point one to two on Figure 4.16.  
This refers to the initial shift of fluid from the upper body to the lower legs, and usually 
lasts about 15 to 20 seconds before the slope decreases significantly.  CCT is the value of 
CC at the end of HUT/LBNP normalized by the time of stress, or the slope of the line 
from point 1 to 3., This represents the total fluid shift during the orthostatic stress.  CCR is 
the value that the CC recovers to at the end of recovery, normalized by the amount of 
time up to that point, given by the slope of the line from point one to four.  This slope 
represents the amount of fluid left in the lower leg several minutes after the end of the 
orthostatic test.  Point four is the lowest value that CC reaches during the recovery 
period, which usually occurs near the end of the recovery period; however, motion 
artifact or drift in the signal sometimes required this value to be sampled a couple 
minutes before the end of the five minute recovery period.  There was no change in CCI 
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 or CCT after training, nor were there any differences between gender or training groups.  
On the other hand, CCR was increased after training (main effect), especially in the active 
subjects (interaction effect), Figure 4.17.  Both active men and active women increased 
CCR after training, while passive women decreased CCR after training (marginally 
significant, p = 0.07). 
 
Figure 0.17: CCR by gender and training group. 
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 Spectral Power Analysis of Responses to HUT/LNBP Test Before and 
After Artificial Gravity Training 
 
 Power spectrum analysis of arterial pressure and RR interval data has been used 
as a non-invasive index of sympathetic (low frequency, LF, 0.04 – 0.15 Hz) and 
parasympathetic (high frequency, HF, 0.04 – 0.15 Hz) nervous system control (1, 41, 98).  
In addition to analyzing the power spectrum of AP and HR, power spectrum of SV, EDV, 
CO and TPR was estimated to determine if artificial gravity training had any effect on 
these indices. 
 
Arterial Pressure  
Head-up tilt and LBNP increased low-frequency spectral power of blood pressure, 
Figure 4.18.  Spectral power during LST4 was higher than all segments other than -20 
mmHg LBNP. 
 
Figure 0.18: Low frequency AP spectral power averaged for all subjects.  
 
Low frequency AP spectral power was not affected by training, and there were no gender 
or training protocol differences.  High frequency spectral power was increased by stress 
as well, but only during -20 mmHg and LST; tilt-induced HF spectral power was not 
significantly greater than control, Figure 4.19. 
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Figure 0.19: High frequency spectral power averaged for all subjects.  
 
High frequency spectral power in men was lower than in women, Figure 4.20a.  Women 
decreased high frequency power as a result of training (p = 0.02) while men tended to 
increase power with training (NS), Figure 4.20b.   
 
Figure 0.20: (a) High frequency AP spectral power by gender and (b) by gender and day.  
 
Heart Rate 
Orthostatic stress increased low frequency spectral power of heart rate (HUT/-
20mmHg LBNP/LST4 all higher than control and recovery, Figure 4.21a).  Artificial 
gravity training increased low frequency spectral power at -20mmHg and LST4, Figure 
4.21b. 
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* *
Figure 0.21: (a) Low frequency HR spectral power averaged across all subjects and (b) separated by 
day.  *Significant effect of training. 
 
Orthostatic stress had the opposite effect on high frequency HR spectral power, Figure 
4.22a.  Spectral power at -20mmHg LBNP and LST4 was significantly lower than in 
control and recovery.  There was a marginally significant difference in gender (women > 
men, p = 0.07), Figure 4.22b. 
 
* * *
*
Figure 0.22: High frequency HR spectral power averaged across all subjects and (b) separated by 
gender.  *Significant difference between gender. 
 
Stroke Volume 
Low frequency spectral power of stroke volume decreased during HUT, but was 
independent of orthostatic stress level, Figure 4.23a.  Both supine values were higher than 
tilt, -20 mmHg LBNP and LST4 (which are not statistically different than each other).  
An unexpected result was that LF spectral power was higher in recovery than in control.  
This effect was compounded after training, Figure 4.23b.     
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Figure 0.23: (a) Low frequency SV spectral power across all subjects and (b) separated by day. 
 
High frequency spectral power of stroke volume was not affected by orthostatic stress 
level.  There was no main gender effect, although men did show higher power after 
training than before, Figure 4.24. 
 
Figure 0.24: High frequency SV spectral power for men and women, before and after training.  
 
Cardiac Output 
Low frequency cardiac output spectral power tended to be lower during 
orthostatic stress than in control, but this effect was only significantly different between 
control and -20 mmHg LBNP, Figure 4.25.  Similar to stroke volume, LF spectral power 
was elevated during recovery. 
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Figure 0.25: Low frequency CO spectral power averaged across all subjects.  
 
High frequency spectral power of cardiac output was decreased by HUT alone, Figure 
4.26.  Application of -20 mmHg LBNP increased HF CO spectral power (p = 0.06) and 
CO power remained elevated during the last 4 minutes of stress (p < 0.05).   
 
Figure 0.26: High frequency CO spectral power averaged across all subjects.  
 
End Diastolic Volume 
End diastolic volume LF spectral power behaved in a fashion similar to cardiac 
output, Figure 4.27.  There was no significant difference between control and HUT, but 
power at -20 mmHg LBNP was statistically lower than control.  Power difference 
between control and LST4 was only marginally significant (p = 0.06).  Also like cardiac 
output LF power, recovery power was significantly greater than all other stress levels, 
including supine control.  There were no significant effects in high frequency EDV 
spectral power. 
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Figure 0.27: Low frequency EDV spectral power averaged across all subjects.  
 
Total Peripheral Resistance 
Orthostatic stress increased low frequency TPR spectral power, Figure 4.28.  
Control and recovery power were both significantly lower than power during all levels of 
stress.  Power was not different during tilt, -20 mmHg LBNP and LST4.   
 
Figure 0.28: Low frequency TPR spectral power averaged across all subjects.  
 
There were no main gender or training day effects, though there was an interaction effect 
between gender/day/stress level, Figure 4.29.  Women’s low frequency TPR power in tilt 
and LST4 was significantly higher than the power of all other groups (women before, 
men before, men after) during these two stress levels.   
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Figure 0.29: Low frequency TPR spectral power for men and women, before and after training.  
 
High frequency spectral power of TPR was also elevated during orthostatic stress, Figure 
4.30a.  Power during Tilt, -20 mmHg and LST4 was higher than power during control 
and recovery, with LST4 HF power being higher than all levels.  Women had higher HF 
TPR power than did men, Figure 4.30b.  There was no effect of training.  
 
Figure 0.30: (a) High frequency spectral power averaged across all subjects and (b) by gender.  
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 Responses to OLBNP Test Before and After Artificial Gravity Training 
 
 
 
Arterial Pressure  
 Arterial pressure amplitude response tended to decrease as input frequency 
increases, Figure 4.31a.  Amplitudes at 0.10 Hz, 0.125 Hz and 0.15 Hz were lower than at 
0.01 Hz.  At 0.04 Hz; the amplitude response was significantly higher than the response 
at all frequencies except for 0.01 Hz.  There were no other gender, protocol or day 
effects, although there was a gender by protocol by segment effect; active women had a 
higher amplitude response than passive women at 0.04 Hz, and higher than active men at 
0.04 Hz and 0.08 Hz.  Passive women had a higher amplitude response at 0.01 Hz than 
did passive men, Figure 4.31b. 
 
Figure 0.31: (a) AP amplitude response averaged across all subject and (b) by gender and training 
group.  
 
 In general, AP phase response did not vary with input frequency, except at 0.08 
Hz, Figure 4.32.  The AP phase response at this frequency was significantly higher than 
the response at all other input frequencies. 
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Figure 0.32: AP phase lags averaged across subjects.  
 
Heart Rate 
 Heart rate amplitude response was significantly higher at the two lowest input 
frequencies, 0.01 Hz and 0.02 Hz than at all other input frequencies, Figure 4.33a.  There 
was no change in amplitude response from 0.04 Hz to 0.15 Hz.  The only gender 
difference occurred at 0.01 Hz, where women had a higher amplitude response than did 
men, Figure 4.33b. 
 
*
Figure 0.33: (a) HR amplitudes averaged across all subjects and (b) by gender.  *Significant 
difference between gender. 
 
 There was no overall effect of artificial gravity training, although there were a few 
training day interactions between protocol and segments, Figure 4.34 below.  At the 
slowest input frequency, 0.01 Hz, active training decreased HR amplitude.  This 
amplitude response (at 0.01 Hz) for the active group after training was lower than the 
responses for the passive group on both test days.  At the second slowest input frequency, 
0.02 Hz, passive training increased HR amplitude. 
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Figure 0.34: HR amplitude for actives (a) and passives (b), before and after training.  
 
Increased input frequency was associated with a slower response, Figure 4.35.  
There was no difference between the phase lags at 0.01 to 0.04 Hz; however, the phase 
lag at these three frequencies were significantly lower than the lag at each of the input 
frequencies from 0.08 to 0.15 Hz.  Similar to the lag at the three lowest frequencies, the 
lag at the 3 highest frequencies were not different from each other. 
 
Figure 0.35: HR phase lags averaged across all subjects.  
 
While there was no overall gender difference in the phase response, women 
responded differently than men at higher input frequencies, Figure 4.36 below.  Women 
significantly increased phase lags from 0.04 Hz to 0.08 Hz, and nearly significantly (p = 
0.08) increased phase lags from 0.08 to 0.10 Hz.  Men did not have these slower 
responses from 0.04 to 0.08 Hz (p=0.42) or from 0.08 to 0.10 Hz (p=0.59).  Additionally, 
women’s phase lags at 0.125 and 0.15 Hz was higher than at 0.08 Hz, while there was no 
difference in phase for men from 0.08 to 0.15 Hz. 
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* *
*
Figure 0.36: HR phase lags by gender.  *Significant gender difference. 
 
Stroke Volume 
Stroke volume amplitude during the slowest input frequency was higher than the 
response at every other input frequency, Figure 4.37.  Stroke volume amplitude response 
at 0.02 Hz was higher than the response at 0.08, 0.125 and 0.15 Hz.   
 
Figure 0.37: SV amplitudes averaged across all subjects.  
 
There was no difference between gender, but there was a training effect; stroke 
volume amplitude response was higher in passive subjects after training than before 
training, Figure 4.38.  There was no difference in the active subjects. 
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Figure 0.38: SV amplitudes for active (a) and passive (b) groups, before and after AG training.  
 
In general, phase lag increased as input frequency increased, Figure 4.39a.  Phase 
at 0.01 Hz was lower than at 0.04, 0.10, 0.125 and 0.15 Hz. Phase lag increased from 
0.10 to 0.125 Hz and from 0.125 to 0.15 Hz.  At 0.04 Hz, phase lag was higher than at 
0.01, 0.02 and 0.08 Hz.  Men had significantly lower phase lags than did women, Figure 
4.39b. 
 
Figure 0.39: (a) SV phase lags averaged across all subjects and (b) by gender.  
 
There was not an overall protocol or training effect, although there was an 
interaction term between training protocol and training day by input frequency (3 way 
interaction), Figure 4.40.  The phase lag appears to reach a local maximum at 0.04 Hz in 
active subjects before and after training, as well as passive subjects before training; 
however, the phase response at 0.04 Hz after passive training is lower than those from 
these 3 groups. 
 51
  
Figure 0.40: SV phase lags for active (a) and passive (b) subjects, before and after AG training.  
 
Cardiac Output 
Cardiac output amplitudes were not affected by input frequency, Figure 4.41.  
There were no differences in gender, training protocol or training day. 
 
Figure 0.41: CO amplitudes averaged across all subjects.  
 
Phase lag tended to increase with increasing LBNP input frequency, Figure 4.42a.  
Phase lag at 0.01 Hz was lower than at all other frequencies, and except for the decrease 
from 0.04 to 0.08 Hz, phase lag increased with each increase in input frequency from 
0.02 to 0.15 Hz. 
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Figure 0.42: (a) CO phase lags averaged across all subjects and (b) separated by gender.  
 
There was no phase difference between training groups, and no over all gender or 
training day effect, although there was a difference in the way men and women 
responded to various input frequencies, Figure 4.42b.  Men increased phase lag from the 
slowest input to 0.02 Hz, while women’s response was not different for the two slowest 
frequencies.  This trend was similar at the two highest frequencies; women showed no 
difference, while men increased phase lag from 0.125 to 0.15 Hz.   
 
End Diastolic Volume 
The amplitude of the EDV response was higher for the 0.01 Hz input than for the 
next two (0.02 and 0.04 Hz) input frequencies, as well as the two fastest (0.125 and 0.15 
Hz) frequencies, Figure 4.43.  The amplitude response at 0.04 Hz was lower than that at 
0.10 Hz. 
 
Figure 0.43: EDV amplitudes averaged across all subjects.  
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 There was no difference in the EDV phase response to the 4 slowest input 
frequencies, although the phase at these 4 frequencies was significantly lower than each 
of the phase responses during the fastest three frequencies, Figure 4.44.  The response of 
EDV to the LBNP input went farther out of phase for each increase in input frequency 
from 0.08 to 0.15 Hz (increase from 0.10 to 0.125 only marginally significant, p = 0.07).  
There were no differences in the EDV amplitude or phase response between gender, 
training group or tilt day. 
 
Figure 0.44: EDV phase lags averaged across all subjects.  
 
Total Peripheral Resistance 
The TPR amplitude response was independent of input frequency, but only 
marginally so (p = 0.0579, Figure 4.45a).  There was no training protocol effect, or effect 
of tilt day, although there was a difference in gender; women had a higher TPR amplitude 
response than men, Figure 4.45b. 
 
Figure 0.45: (a) TPR amplitudes averaged across all subjects and (b) separated by gender.  
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 Although the TPR amplitude response was independent of input frequency, TPR phase 
lag increased with each increase in LBNP input frequency, Figure 4.46. 
 
Figure 0.46: TPR phase lags averaged across all subjects.  
 
There was no overall gender effect, training protocol or tilt day effect, although 
there was a protocol by day effect; active men had lower TPR phase lags after training, 
Figure 4.47a.  Active men’s phase lag after training was also lower than the phase lag of 
active women on both days (Figure 4.47c) and passive women on both days (Figure 
4.47d).  It was only marginally significantly lower than passive men after training (Figure 
4.47b, p = 0.071). 
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Figure 0.47: TPR phase lags, before and after training for active men (a, top left), passive men (b, top 
right), active women (c, bottom left) and passive women (d, bottom right).  
 
Calf Circumference 
Calf circumference amplitude decreased with increasing input frequency from 
0.01 Hz to 0.08 Hz, but did not change from 0.08 Hz to 0.15 Hz, Figure 4.48a.  Women 
had a lower amplitude response at 0.01 Hz than did men, Figure 4.48b.  Women did not 
significantly decrease amplitude response from 0.01 to 0.02 Hz as did men, nor did they 
have any difference in amplitude response from 0.08 Hz to 0.15 Hz; men’s amplitude 
response at 0.125 Hz was lower than at 0.08 Hz, and nearly significantly lower at 0.15 Hz 
(compared to 0.08 Hz, p = 0.065). 
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*
Figure 0.48: (a) CC amplitudes averaged across all subjects and (b) separated by gender.  
*Significant gender difference. 
 
In contrast to the decreasing amplitude response of CC, phase lag increased with 
faster input frequencies from 0.02 Hz to 0.08 Hz, Figure 4.49.  There was no phase 
difference from 0.08 Hz to 0.15 Hz.  
 
Figure 0.49: CC phase lags averaged across all subjects.  
 
Active training tended to decrease phase lag (p = 0.09) while passive training appeared to 
have the opposite effect (NS, p = 0.25), Figure 4.50.  There was a significant effect of 
training (decreased lag) in the active subjects at input frequencies of 0.10, 0.125 and 0.15 
Hz, Figure 4.50a.  Additionally, the phase response of active subjects after training was 
nearly independent of input frequency; other than the responses at 0.04 and 0.08 Hz, 
which were higher than at 0.01 Hz, there were no other statistical differences between 
any frequencies.  The passive subjects, however, showed considerable changes with 
increasing input frequency after training, Figure 4.50b.  Not only did the phase lag 
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 increase from 0.01 to 0.02 Hz, and 0.02 to 0.04 Hz, the phase lags at 0.01 and 0.02 Hz 
were lower than at all other frequencies, unlike the active subjects after training. 
 
* * *
Figure 0.50: CC phase lags for (a) active and (b) passive subjects, before and after training.  
*Significant effect of training. 
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 Baroreflex Analysis 
Training 
Baroreflex analysis was performed on only passive subjects during training.  The 
data from the 1 Gz and 2.5 Gz segments were compared to data from supine control and 
70º HUT for these same subjects.  For both BRS and NNS, supine control and 1.0 Gz 
rotation were not significantly different from each other, nor were 2.5 Gz rotation and 70º 
HUT.  However, both supine control and 1.0 Gz rotation were significantly different from 
both 2.5 Gz rotation and 70º HUT, Figure 4.51.  There were no differences between 
gender, and no effect of training.   
 
Figure 0.51: (a) Baroreflex sensitivity averaged across all passive subjects during artificial gravity 
training. (b) Normalized number of baroreflex sequences averaged across all passive subjects during 
artificial gravity training.  
 
HUT/LBNP 
The sensitivity of the baroreflex decreased from control to HUT, but did not 
change from HUT to -20 mmHg LBNP, nor from -20 mmHg LBNP to LST4, Figure 
4.52a.  The recovery value of BRS was higher than the other 4 segments.  The 
normalized number of baroreflex sequences increased from control to HUT, then 
decreased from HUT to -20 mmHg LBNP, Figure 4.52b.  The number of sequences 
during HUT was significantly higher than in all other segments. 
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Figure 0.52: (a) Baroreflex sensitivity averaged across all subjects during HUT/LBNP test. (b) 
Normalized number of baroreflex sequences averaged across all subjects during HUT/LBNP test.  
 
There were no differences between gender, training protocol, or as a result of training, 
although there was an interaction between protocol and day.  Passive subjects had a lower 
number of sequences after training, Figure 4.53.  Passive subjects before training did not 
have the decrease in sequences from HUT to -20 mmHg and LST4 that the other three 
groups (active before, active after, passive after) exhibited. 
 
Figure 0.53:  Normalized number of baroreflex sequences averaged for (a) active and (b) passive 
subjects, before and after training.  
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 Blood Assay Results 
 
Norepinephrine 
 Norepinephrine values increased with orthostatic stress, and then decreased 
during recovery; however, the recovery values were still higher than control values, 
Figure 4.54a.  When compared by gender, men did not have the decrease in 
norepinephrine from -30 mmHg LBNP to recovery that women exhibited.   
 
Figure 0.54: (a) Norepinephrine averaged across all subjects and (b) separated by gender.  
 
Women had lower norepinephrine in recovery (compared to -30 mmHg LBNP) both 
before and after training, Figure 4.55.  While not significant, men appeared to increase 
norepinephrine in recovery after training (men recovery, before vs. after, p = 0.077).   
 
Figure 0.55: Norepinephrine before and after training by gender.  
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 Epinephrine 
Female epinephrine data were unavailable.  Men increased epinephrine from 
control to HUT (plus -30 mmHg LBNP) and recovery, although there were no effects of 
training or training protocol, Figure 4.56. 
 
Figure 0.56: Epinephrine from men, before and after training.  
 
Aldosterone 
 Aldosterone was higher in the third blood draw (at the time of pre-syncope) than 
during the first two blood draws, Figure 4.57.  There were no differences in gender, or 
effects of training or training protocol. 
 
 
Figure 0.57: Aldosterone averaged across all subjects. 
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 Plasma Renin Activity 
 Similar to aldosterone, plasma renin activity (PRA) was higher at pre-syncope 
than during control or HUT (plus -30 mmHg LBNP), Figure 4.58.  There were no 
differences in gender, or effects of training or training protocol. 
 
 
Figure 0.58: Plasma renin activity averaged across all subjects. 
 
Total Protein 
 Total protein (TP) increased from control to HUT (plus -30 mmHg LBNP) to pre-
syncope, Figure 4.59a.  There were no effects of training or training protocol, although 
women did not increase TP from HUT (plus -30 mmHg LBNP) to pre-syncope, Figure 
4.59b.   
 
 
Figure 0.59: (a) Total protein averaged across all subjects, and (b) separated by gender. 
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 Arginine Vasopressin 
 Arginine vasopressin (AVP) increased from blood draws #1 through #3 in men, 
but there were no changes in AVP in women with increasing orthostatic stress, Figure 
4.60a.  After training, men had the same control value of AVP, but did not increase AVP 
release with increasing orthostatic stress, Figure 4.60b. 
 
 
*
*
Figure 0.60: Arginine vasopressin for (a) men and women and (b) men, before and after training. 
*Significant effect of training. 
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 Chapter 5: Discussion 
Responses to HUT/LBNP 
 
Orthostatic Tolerance 
This research has shown that three weeks of intermittent artificial gravity training 
of 35 minutes a day is capable of improving orthostatic tolerance to a combination 
HUT/LBNP test for normal, ambulatory human subjects.  Exercise accentuates artificial 
gravity training, evidenced by increased tolerance in both male and female active 
subjects, Figure 4.2.  While this is the first study known to increase tolerance in normal, 
ambulatory subjects, exercise combined with AG training has been shown in the past to 
ameliorate the effects of simulated microgravity via dry water immersion (126, 127).  
Those studies used Gz exposures ranging from 0.8 to 2.0 Gz, from 40 minutes to a couple 
hours a day.  Results from these water immersion studies indicate that artificial gravity 
training was optimal when exercise was coupled with centrifugation from 0.8 to 1.6 Gz, 
for 2 hours a day.  Because our ambulatory subjects, especially those who exercised, 
showed improved tolerance after only 35 minutes a day of training, it is logical to 
hypothesize that this protocol would maintain or improve tolerance for subjects who have 
adapted to microgravity.  
While there was no statistically significant improvement in our passive subjects, 
nor a significant difference between passive men and women, it appeared that there was a 
trend for artificial gravity training to improve tolerance in passive men, while slightly 
reducing tolerance in passive women, Figure 4.2.  Other studies have shown improved 
cardiovascular function with artificial gravity alone (without exercise), but these studies 
did not test the effects of centrifugation on tolerance to an orthostatic stress (26, 75).  
Iwasaki et al reported two, 30-minute sessions a day, for four days, of short arm 
centrifugation prevented HDBR deconditioning effects on plasma volume and baroreflex 
function, but was unsuccessful in preventing loss of exercise capacity (75).  These results, 
along with our findings, suggest that exercise is an important part of the artificial gravity 
countermeasure to orthostatic intolerance.   
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 Although we were unable to measure work intensity via MV02 during our HPC 
training protocol, heart rate responses of active subjects during the ramp-up from 1 Gz to 
2.5 Gz reached 185 ± 5 bpm which, along with the subject’s assessment, indicated that 
these ramp-up periods required high intensity work.  Therefore the active subjects 
received artificial gravity training via centrifugation, acute, high intensity exercise during 
Gz level increments, and moderate endurance exercise (average HR of 146 ± 6 bpm 
during the 2.5 Gz level).  Acute, high intensity exercise alone near the end of a simulated 
microgravity study has been suggested to be effective in preventing the deconditioning 
effects of simulated microgravity and orthostatic intolerance (28, 29, 39).  However, 
when used as a countermeasure during actual spaceflight, the response to the post-flight, 
standard stand test was no different in the exercise versus the control group (94).  The 
addition of artificial gravity while exercising could help to prevent orthostatic intolerance 
in astronauts returning from space, but at present the technique has not been tried. 
 While the active female group improved tolerance after training, they were 
statistically less tolerant to HUT/LBNP than their male counterparts.  This was true of the 
passive group as well—all men were more tolerant to HUT/LBNP than were women.  
This dichotomy was expected and has been well documented (23, 43, 45, 49, 93, 136, 
139).  This decreased tolerance to HUT/LBNP is most likely caused by increased pooling 
in the pelvic region in women (93, 139).  It is encouraging that the active women in this 
protocol improved their tolerance to HUT/LBNP, and possible mechanisms for this 
improvement are discussed below. 
 
Hemodynamic Responses 
 The hemodynamic responses to HUT were as expected; heart rate and vascular 
resistance increased concomitantly with a decrease in stroke volume, cardiac output and 
end diastolic volume, resulting in only minor changes in arterial pressure.  It should be 
noted that the absolute values of cardiac output reported in this study are higher than 
values previously reported, although changes from baseline are within normal ranges.   
Men responded to HUT and -20 mmHg LBNP by increasing blood pressure, 
while women decreased blood pressure in response to -20 mmHg LBNP.  This drop in 
blood pressure when the vacuum was activated could be indicative of increased pooling 
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 in the splanchnic regions, which lie partially inside the vacuum chamber.  Women also 
had a higher heart rate response to -20 mmHg LBNP than did men, although their supine 
control values were similar, indicating that their cardiovascular systems were more 
stressed at this early point in the HUT/LBNP test than were men’s.  This increase in heart 
rate without any changes in vascular resistance, suggests that women may respond to 
stress through vagal, rather than sympathetic mechanisms (23, 41, 49).   
 Artificial gravity training decreased arterial pressure, total peripheral resistance, 
and increased stroke volume for all subjects, and increased cardiac output in men.  Men 
had a higher stroke volume and cardiac output than did women, although these gender 
differences disappear when values are normalized by body surface area.  Increased 
cardiac output and stroke volume could be the result of increased circulating blood 
volume.  While this variable was not measured in our study, other investigators have 
reported increased blood volume with high Gz training (26) and plasma volume 
restoration during HDBR with AG training (75).  The decrease in mean TPR after 
training could have improved orthostatic tolerance via two mechanisms.  First, a lower 
vascular resistance could indicate a greater  “vasoconstrictor reserve,” or the degree to 
which a subject can increase TPR to maintain blood pressure (51, 108).  Results from this 
study (Figure 4.15) however, yielded diminished TPR during orthostatic stress, including 
at pre-syncope.  If these subjects increase vasoconstrictor reserve capacity, they did not 
utilize it by increasing TPR near pre-syncope after training.  Secondly, decreased 
arteriole resistance coupled with enhanced venomotor tone (not measured) could increase 
venous return which would increase cardiac output through increased stroke volume.  
Improved vascular function becomes very important when dealing with post-spaceflight 
orthostatic intolerance because one of the underlying mechanisms of this intolerance is 
diminished TPR response to tilt (7, 91, 92, 136). 
 Overall decreased TPR after training could partly be due to larger leg muscles 
(more vascular beds) after training, especially in the active subjects.  Exercise training is 
well known to increase muscle size (102, 120, 121); in fact, in a nearly identical exercise 
with AG protocol, magnetic resonance imaging of the quadriceps showed significant 
volume (4% to 6% each, p < 0.0001) increase in all four muscles (57).  We report a larger 
calf recovery volume after training in active subjects (Figure 4.17), with no change in 
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 passive men and a tendency for passive women to decrease CCR after training (p = 0.07).  
This indicated that more fluid remained in the calf during recovery after training, even 
though the increase in calf size during maximal stress was not different (no increase in 
CCT).  This suggests that the active subjects had larger calf sizes before the onset of 
HUT/LBNP after training, and the same relative increase in CC (no change in CCT) 
yielded a larger pooling of fluid in the calf (larger CCR). 
 Increased resting vasodilation after training could be the result of increased shear-
mediated nitric oxide (NO) activity.  Exercise training has been shown to increase NO 
function, a result of increased flow in the legs due to metabolic demands of exercising 
muscle (56).  It is probable that our centrifuge training protocol accentuates this effect by 
increasing fluid shifts to the lower legs.  However, this shifting of fluid to the legs via 
short arm centrifugation has been shown to reduce cutaneous blood flow in the legs, most 
likely through peripheral vasoconstriction caused by unloading of baroreceptors (132).  
Therefore, during training, a local autacoid-mediated dilation could counteract extrinsic 
sympathetically-driven constriction.  It is possible that the magnitude of these opposing 
mechanisms during hypergravity helped to improve tolerance to orthostatic stress. 
 The above argument is not as persuasive when considering female subjects.  
Active women did have a larger CCR, however, they did not show a decrease in TPR after 
training, Figure 4.15.  It is important to note that active women already had low mean 
TPR values before training that were already as low as those reached by the other three 
groups after training (active women before < passive women before and after, p = 
0.0175, and not significantly different from both male groups after training).  These 
subjects may have had lower TPR before training due to 1) circulating estrogen (129, 
143) (this does not explain the difference between female groups) and 2) even though an 
effort was made to randomize these female subjects, at baseline the active women were 
more athletic than their passive counterparts. 
 
Neurohumoral Responses 
 The neurohumoral responses to orthostatic stress reported in this study are similar 
to those reported previously (77).  As expected, norepinephrine and epinephrine were 
enhanced during the second blood draw (during HUT with -30 mmHg LBNP).  
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 Aldosterone and PRA were not significantly enhanced until the 3rd blood draw (at the 
point of pre-syncope).   
 Total protein concentrations increased with increasing orthostatic stress, which is 
indicative of fluid filtration out of the vascular system.  Women did not have a significant 
increase in TP concentration from blood draw #2 to #3.  This is most likely due to the 
small amount of time between these blood draws for women.  Because women developed 
presyncopal symptoms near the time of the second blood draw, the pre-syncopal (3rd 
draw) blood draw often occurred right after (usually within 2 minutes) this second blood 
draw.  Men have a larger TP concentration at the time of their pre-syncopal blood draw 
because they were able to withstand a longer stress, allowing for more fluid filtration. 
 Arginine vasopressin increased with increasing orthostatic stress in men (although 
these small changes were not large enough to impact blood pressure regulation), but did 
not change in women.  Also, men had higher levels of AVP than did women.  This has 
been supported by other researchers (74, 114), and an inability of women to rely on AVP 
response to orthostatic stress might be one of the factors involved in their overall reduced 
tolerance to LBNP.  Men had smaller AVP responses to stress after AG training, although 
their control values were not different.  This could be evidence that AG-trained men 
relied more on neurally-mediated peripheral vascular responses to maintain tolerance 
rather than through neurohumoral responses. 
 
Spectral Power 
 Low frequency (0.04 – 0.15 Hz) spectral power of blood pressure increased in all 
subjects in response to orthostatic stress (control and recovery < HUT < -20 mmHg 
LBNP and LST4), Figure 4.18.  This was an expected result, indicating increased 
sympathetic nervous system activity with the onset of orthostatic stress.  Low frequency 
oscillations in arterial pressure and RR interval have been directly correlated to 
oscillations in sympathetic nerve discharge (52, 98).  In our study, this index of increased 
sympathetic activity was supported by increased circulating norepinephrine in all subjects 
during blood draws at -30 mmHg LBNP and ninety seconds after presyncopal symptoms 
developed, and increased epinephrine in all male subjects (female epinephrine data was 
unavailable).   
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  These low frequency oscillations in blood pressure are most likely caused by low 
frequency oscillations in vascular resistance (78, 115, 116).  This study showed increased 
LF TPR spectral power during all levels of orthostatic stress (HUT, -20 mmHg LBNP, 
LST4) compared to supine control and recovery.  Women had a higher LF TPR response 
to HUT than did men after training, indicating that women had higher sympathetic 
regulation of blood pressure after AG training.  This higher LF TPR response to HUT 
was present in both female groups, and did not differentiate between active and passive 
subjects.  In active women, there was no change in mean TPR after training, unlike the 
other training groups, indicating that enhanced vasomotion may have played some role in 
improving tolerance to HUT in active women.   
Another index of autonomic regulation is high frequency (0.15 – 0.40 Hz) spectral 
power of heart rate and blood pressure.  In contrast to LF power, a decrease in HF power 
has been shown to correlate with decreased parasympathetic outflow (52).  This is seen in 
the current group of subjects as a decrease in HF heart rate power during -20 mmHg 
LBNP and LST4, compared to supine control and recovery, Figure 4.22a.  Women had 
significantly higher HF arterial pressure power and nearly higher heart rate HF power 
than men (p = 0.07, Figure 4.22b).  Increased AP high frequency power could be a direct 
effect of breathing (106) and higher HR HF could indicate that women had greater vagal, 
rather than sympathetic, control of heart rate.  This is not an uncommon finding, and has 
been suggested by several researchers (23, 41, 49).  Additionally, women decreased HF 
arterial pressure power after training, perhaps indicating higher sympathetic control of 
blood pressure.  Changes in HF arterial pressure power coupled with a HUT-induced 
increase in LF TPR power after training suggests that female subjects may have 
responded to AG training by increasing sympathetic regulation of blood pressure, with 
less reliance on parasympathetic control.  Overall, however, women had a higher index of 
parasympathetic control (HF heart rate), which is probably one of the reasons they have 
overall less tolerance to orthostatic stress than do men (49).   
Baroreflex Activity 
 
 Analysis of the cardiac baroreflex response before and after training, as well as 
during training, also provides insight into the effects of artificial gravity training on 
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 cardiovascular responses to orthostatic stress.  Decreases in baroreflex sensitivity and  
increases in the normalized number of sequences from supine control to head-up tilt were 
expected, and are well documented (4, 72, 73, 117).  However, there were no differences 
in BRS or NNS between supine control (0 Gz) and supine 1 Gz rotation.  This implies that 
1 Gz rotation does not stimulate carotid or aortic baroreceptors above the level of that 
measured for supine control.  Rotation producing 2.5 Gz at the feet was required to shift 
enough fluid to unload cardiac baroreceptors in order to stimulate a response equivalent 
to 70º HUT.  Watenpaugh et al suggested that (on a 1.8 m centrifuge), 5 Gz might be 
needed at the feet to elicit a response similar to standing (132), but the present study 
verified that 2.5 Gz on a 1.9 m centrifuge was sufficient to accomplish this. 
 There was some variability associated with subject’s heights; however, in general 
1.0 Gz at the feet is approximately 0.2 to 0.25 Gz at the heart level, and even smaller at 
the carotid baroreceptors.  Similarly, 2.5 Gz acceleration at the feet does not produce 1.0 
Gz at the heart; it is approximately 0.7 to 0.75 Gz at the heart.  Based on these physical 
calculations alone, one would not expect 2.5 Gz (at the feet) acceleration to stimulate the 
cardiac baroreceptors as much as 70º HUT (sin70º * 1Gz ≈ 0.94 Gz), yet our spontaneous 
baroreflex analysis would suggest otherwise.  This could be caused by indirect unloading 
of the baroreceptors by fluid sequestering in the legs due to the 2.5 Gz at the feet.  
Although the gravity gradient along the body is linearly related to radial distance from the 
center of centrifugation, the hydrostatic gradient is non-linear (ω2r2 as opposed to ω2r).  
This causes a large shift of fluid to the feet, which could unload the baroreceptors and 
explain the similarity in baroreflex responses at supine 2.5 Gz and 70º HUT. 
It is possible that these AG training-induced shifts of fluid to the feet stimulate 
cardiopulmonary baroreceptors more than aortic or cardiac baroreceptors.  These low-
pressure receptors act mainly through sympathetic stimulation of the vasculature (105), 
which might explain the enhanced vascular resistance responses seen in our active 
subjects after training. 
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 Responses to OLBNP 
 
 One of the “regulated” variables during cardiovascular stress is blood pressure.  
Previous studies analyzing the control of blood pressure in dogs exposed to sinusoidal 
acceleration at frequencies similar to this study indicated that AP was centrally regulated 
at very low frequencies (below 0.012 Hz), and that these central mechanisms were less 
effective at higher frequencies (82, 103).  More recent human studies using oscillatory 
lower body negative pressure yielded similar results (88).  Brown et al determined that 
cerebral blood vessels were unable to modulate fluctuations in arterial pressure (in 
response to OLBNP), and that this effect was more pronounced at higher frequencies .  
Levenhagen et al determined in a similar group of ambulatory men, that arterial pressure 
fluctuations were minimized at all OLNBP input frequencies.  However, when the 
amplitude of arterial pressure oscillations were normalized by the amplitude of fluid 
volume shifted (either calf circumference or central venous pressure oscillations), AP 
amplitudes increased with increasing input frequencies, peaking at 0.08 Hz (88).   
Similar to Levenhagen et al, our results show relatively stable (<3 mmHg) AP 
amplitudes across the range of input OLBNP frequencies.  Amplitudes at 0.10 and 0.125 
Hz were slightly lower than at 0.01 Hz, indicating either smaller volume of fluid was 
being shifted or enhanced regulation occurred at higher frequencies.  In the present study, 
the largest amplitude responses occurred at 0.04 Hz and this could be the effect of TPR 
timing in response to OLBNP—both AP and TPR were in phase at this frequency, 
meaning maximum vasoconstriction was occurring in sync with maximum blood 
pressure, which could yield larger oscillations in AP (Figures 4.32 and 4.46).  Also 
similar to Levenhagen, normalization of AP amplitudes with changes in CC indicated 
reduced control of blood pressure at higher input frequencies, Figure 5.1.  Overall, our 
results support the concept that healthy, ambulatory subjects regulated blood pressure 
quite well in spite of large oscillations in cardiac output at lower frequencies and reduced 
control at higher frequencies, where smaller oscillations in fluid volume appear to be the 
principal factor.  
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Figure 0.1: AP amplitudes normalized by CC amplitudes for all subjects.  
 
The phase response of AP was also similar to the human OLBNP study (88).  
Arterial pressure consistently lagged OLBNP input by approximately 180º, except at 0.08 
Hz, where it was about 210º out of phase.  This indicated that blood pressure fell as 
vacuum was applied, as would be expected.   
Levenhagen et al reported decreasing HR amplitudes with increasing OLBNP 
input frequencies.  This study yielded similar results from 0.01 to 0.04 Hz, with no 
changes in amplitude response at higher input frequencies.  It is important to note, 
however, that this study analyzed frequencies higher than those used by Levenhagen et al 
(0.125 and 0.15 Hz), and no predictions can be made about trends from their data past 
0.10 Hz.  This decrease in amplitude with increasing frequency has been suggested as a 
decrease in central neural control; current results (no change in HR amplitude from 0.04 
to 0.15 Hz) suggest no change in neural control, possibly due to the minimal fluid shifts 
at higher input frequencies.  However, examination of the HR phase response suggests 
that HR is responding as needed; even though phase lags were larger at faster input 
frequencies, the actual response time of maximum HR to the maximum pull of OLBNP at 
the 4 fastest frequencies averaged 5 seconds, which is faster than the HR responses to 
input frequencies from 0.01 to 0.04 Hz.  Another interesting observation from timing data 
(as opposed to phase lags in degrees) is that men had a significantly slower HR response 
to OLBNP input than do women (Figure 5.2), implying that heart rate (known to be 
capable of reflex changes in a second) was actually participating in blood pressure 
regulation by buffering other variables that were slower to act in men than in women.     
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Figure 0.2: Heart response time to OLBNP input for men and women   
 
This difference in HR response times in men and women was a main effect of the 
ANOVA, but it can be seen that this is an effect of the low frequency (0.01 – 0.04 Hz) 
inputs.  This is another indication that women respond more vagally than do men, or, 
possibly that women were more stressed than men were at these low LBNP frequencies.  
It is possible that women were more stressed at these low LBNP input frequencies, as 
active women had larger blood pressure oscillations at 0.04 Hz than did active men, and 
passive women had larger blood pressure oscillations at 0.01 Hz than did passive men, 
Figure 4.31b.  An interesting corollary to this difference in HR timing is the timing 
response of TPR to OLBNP, Figure 5.3.  Although not statistically significant, there is a 
trend for male TPR responses to be faster than female responses, again suggesting that 
men have a stronger (faster) sympathetic response to stress than do women.  However, 
women had larger TPR amplitude response than did men at all frequencies (Figure 
4.45b); this might be interpreted as women having larger sympathetic responses, or more 
likely that women were being stressed more severely during LBNP than were men (93, 
138, 139). 
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Figure 0.3: TPR timing response to OLBNP input for men and women.  
 
The forcing function used in this test was oscillatory lower body negative 
pressure; however, in response to OLBNP, the perturbation to the cardiovascular system 
is actually shifting of fluid from the upper body to the lower body.  In this study, an index 
of this shift is a change in calf circumference.  Slower input frequencies allow more time 
for fluid to accumulate in the calf, and this is seen in the larger amplitude responses at 
lower input frequencies, Figure 4.48a.  As input frequency increased, CC amplitude 
decreased from 0.01 to 0.08 Hz, as there was less time for fluid to build up in the calf.  
From 0.08 to 0.15 Hz, there was no change in the amplitude response of CC, indicating 
no difference in pooling in the lower leg during these frequencies.  Swelling of the calf 
during short-term (less than 10 minutes) LBNP appeared to be dominated by shifting of 
fluid to venous spaces (2, 8), and not likely caused by filtration into interstitial spaces.  
However, the results from the present study indicate a difference in the amount of blood 
pooled at low versus high input frequencies.  It is possible that filtration into interstitial 
places may contribute to the amount of fluid shifted for frequencies below 0.08 Hz 
(period of 12 seconds), which accounts for the larger changes in CC at lower than 0.08 
Hz input frequencies; at higher frequencies, it is likely that a significant amount of 
filtration does not occur within 6 to 12 seconds of LBNP (0.15 to 0.08 Hz), which could 
explain why CC amplitudes do not further change with increasing frequencies above 0.08 
Hz. 
 As OLBNP input frequency increased from 0.01 to 0.08 Hz, CC tended to fall 
farther out of phase (Figure 4.49) while, from 0.08 to 0.15 Hz, there was no change in CC 
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 phase lag with respect to input frequency.  However, a steady phase response to 
increasing frequency indicates a decrease in timing in the time domain.  Although there 
were no amplitude or phase changes in input frequencies from 0.08 Hz to 0.15 Hz, the 
calf circumference changes faster in response to faster input frequency, indicating that 
vascular fluid shifts keep up with the OLBNP stimulus. 
After active training, phase lag tended to be diminished (p = 0.09 overall, p < 0.05 
for 0.08, 0.10 and 0.125 Hz inputs, Figure 4.50a).  Although not a significant effect, the 
passive subjects responded in an opposite fashion, tending to increase phase lag after 
training, Figure 4.50b.  This increased speed of response after active training could imply 
increased vascular compliance, yielding a larger change in volume for smaller pressure 
changes (thereby making the calf swell faster with the onset of LBNP); or decreased CC 
response time could be the effect of a larger vascular bed (large muscles) after active 
training.  A larger vascular bed might be construed to be detrimental to maintaining 
orthostatic tolerance, but other results indicate a positive effect of training.  For example, 
active men significantly reduced TPR phase lag (at all input frequencies) after training, 
indicating enhanced responsiveness to OLBNP. 
One could argue that the increased response time of TPR after training is simply a 
response to faster changes in CC dynamics; however, this is not the case.  By subtracting 
CC phase values from TPR phase, one can calculate the vascular resistance response to 
shifting of fluid to the calf.  In doing this, the active men significantly decreased (p = 
0.01) TPR response time to changes in CC, while active women significantly increased (p 
= 0.02) TPR response time to changes in CC after training, Figure 5.4.   
 
 
Figure 0.4: TPR phase response to changes in CC for active men (left) and women (right), before and 
after AG training.  
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While not significant (p = 0.08), women’s TPR response to CC changes tended to 
be slower than men’s.  This slower TPR response to CC changes is independent of 
training, and could be a reason for decreased orthostatic tolerance in women.  As stated 
above, a predominance of literature indicates that men’s cardiovascular control is 
sympathetically dominated, while women respond more vagally.  With these findings in 
mind, comparisons of response times of both TPR and HR to changes in AP were made.  
Similar to the response to changes in CC, TPR responded faster to changes in AP after 
training than before in active men (p = 0.02).  There were no differences in TPR response 
times to AP changes in women, although passive men increased TPR response time 
(slower responses) to changes in AP.  If the vascular resistance response to changes in AP 
is an indicator of training efficacy, then this is strong evidence that exercise is an 
important aspect of AG training in men. 
Unlike the increased responsiveness of TPR to AP changes, HR responses to 
changes in AP were more sluggish after training (in all subjects), Figure 5.5.   
 
Figure 0.5: Heart rate responses to changs in blood pressure before (blue) and after (red) training for 
all subjects. 
 
This could be a result of the ‘decoupling’ effect of AG training – improved 
tolerance via peripheral mechanisms without improvement in cardiac baroreflex 
(discussed below) responses.  The increased response time (slower response) of HR to 
changes in AP was associated with a decrease in HR amplitude at 0.01 Hz for all active 
subjects after training, Figure 4.35a.  Although there was no effect of training or gender, 
0.01 Hz was the only frequency at which OLBNP induced a faster response in TPR than 
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 in HR.  It could be that the body chooses to respond to disturbances in AP via vascular 
mechanisms, but is unable to do so at higher frequencies.     
These TPR and HR results are opposite of those found by Charles, in which 
oscillatory fluid shifts via centrifugation were assessed in two groups (endurance 
exercised trained versus control) chronically instrumented dogs (18).  The conclusions 
from this dog study were that endurance trained dogs had slower TPR responses after 
training, and these endurance trained dogs relied more on HR to buffer changes in blood 
pressure.  The differences between these two studies could be a result of: 1) species, 
Charles studied dogs rather than humans, 2) stimulus, Charles used acceleration on a 
centrifuge to cause fluid shifts while this study used LBNP and 3) training paradigm, the 
endurance trained dogs in Charles’ study were trained in a normal 1 Gz environment 
(treadmill at a 10º incline) while the active men in the present study were trained in an 
oscillatory, but rotational Gz environment. 
Limitations 
 
Although this study was able to show that artificial gravity training was beneficial 
in improving orthostatic tolerance in normal, ambulatory subjects, the subject pool was 
not controlled in any way.  Subjects arrived daily for their training session, then resumed 
their normal lives, so strict experimental control of subjects was not maintained.  
Secondly, MV02 was not assessed, so, even though subjects and input loads were 
matched to that of the 1999 study where this assessment was made, heart rate reached 
during the effort to drive the centrifuge was our only direct assessment of how hard each 
subject was working.  Thirdly, even though subjects were randomly assigned to groups, 
the active female group was more athletic and “in shape” then were the passive females. 
Our HUT/LBNP termination point was subject to a large number of factors, 
including drops in blood pressure and heart rate, as well several measures of subject 
discomfort; stomach awareness, light-headedness, sweating or general discomfort.  While 
the same medical monitor was used for the duration of the study, so that the same pre-
syncopal symptoms were identified both before and training, fewer than half the subjects 
did not exhibit the classic drops in blood pressure and heart rate associated with 
vasovagal syncope, but for other reasons mentioned above the test was terminated. . 
 78
 Another limitation of this study was a lack of plasma volume measurements.  
Other studies have showed changes in plasma and/or blood volumes associated with 
centrifuge studying, and it is unclear if these volume changes are associated with 
improved tolerance.  Additionally, women’s epinephrine and dopamine data were 
contaminated during analysis, and were not suitable for use in this document. 
Finally, there are some aspects of blood pressure regulation that may have been 
effected by AG training which were not measured in this study.  For example, improved 
orthostatic tolerance may have been the result of enhanced cerebral autoregulation (148), 
although much of the evidence in this study points peripheral vasculature mechanisms.    
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 Chapter 6: Conclusions 
The hypothesis of this study was that 3 weeks of artificial gravity training would 
improve orthostatic tolerance in normal, ambulatory subjects.  The results of this study 
indicated that this hypothesis was correct; three weeks of training improved orthostatic 
tolerance by 13% in a group of 26 subjects.  Men were more tolerant to orthostatic stress 
than were women, both before and after training and men had higher blood pressure, 
stroke volume, end diastolic volume and cardiac output than did women  Active subjects, 
regardless of gender, were more improved than their passive counterparts. 
Improved tolerance (of the whole group of subjects) was associated with 
decreased blood pressure and total peripheral resistance after training, as well as 
increased stroke volume.  Improved tolerance in active subjects was associated with 
larger residual calf circumferences during recovery after training, as well as faster CC 
and TPR responses to OLBNP input after training.  After training, all subjects had slower 
HR responses to changes in AP. 
These mechanisms associated with improved tolerance are not a result of 
increased cardiac baroreflex activity, as there were no BRS or NNS changes post-
training.  Also, spontaneous baroreflex analysis yielded no differences between supine 
control and supine 1.0 Gz acceleration, nor between 70º HUT and 2.5 Gz acceleration, 
suggesting that mechanisms other than centrally mediated cardiac baroreflex are 
responsible for any artificial gravity training effects. 
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 Chapter 7: Future Work 
 While this study was successful in improving orthostatic tolerance in normal, 
ambulatory subjects, the impetus behind this research was development of a 
countermeasure to orthostatic intolerance associated with cardiovascular deconditioning 
in spaceflight.  A well documented analog of cardiovascular alterations to microgravity is 
extended bed rest in a 6º head down position.  Future research should be performed to 
assess the efficacy of artificial gravity training in preventing any detrimental effects 
associated with these adaptations to microgravity. 
 Additionally, duration, frequency and intensity of AG training needs to be 
examined in order to determine the best combination of exercise and AG training for its 
use a practical countermeasure.  In optimizing these parameters, new methods of analysis 
should be utilized to determine the effects of AG training.  Specifically, segmental body 
impedance should be used to assess fluid volume shifts not only during a provocative 
HUT/LBNP test, but also during AG training.  This type of analysis would help to 
answer previously unexplored aspects of AG training, such as volume changes in 
different regions of the body under varying levels of AG and exercise. 
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 Appendices 
Appendix A: Subject and Data File information 
 
Table 1: Anthropomorphic Data for All Subjects 
  Gender 
Training 
Group 
Age 
(yr) Height (cm) 
Weight 
(kg) 
A male active 24 180 82 
B male passive 37 182 73 
C male passive 50 180 100 
D male active 37 184 71 
E male passive 34 178 80 
F male passive 34 173 72 
G male active 34 187 86 
H male passive 30 155 77 
I male active 29 183 84 
J male active 46 170 73 
K male active 21 173 82 
L male active 29 188 89 
M male passive 32 176 78 
N male passive 26 180 82 
O male passive 27 188 90 
AW female passive 37 163 62 
BW female passive 29 171 57 
CW female active 35 172 60 
DW female passive 28 164 52 
EW female active 25 159 58 
FW female passive 39 164 56 
GW female active 29 184 65 
HW female active 22 169 61 
IW female passive 27 158 72 
JW female passive 26 147 51 
KW female active 31 170 62 
LW female active 34 142 83 
MW female passive 28 159 55 
NW female active 44 168 71 
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Table 2: Channel Assignments for Data Processing 
Channel Variable 
1 Arterial Pressure 
2 Systolic Pressure 
3 Diastolic Pressure 
4 Mean Arterial Pressure 
5 ECG 
6 Heart Rate 
7 RR Interval 
8 Stroke Volume 
9 Cardiac Output 
10 End Diastolic Volume 
11 Thoracic Fluid Index 
12 Calf Circumference 
13 Tilt Angle 
14 LBNP Level 
15 Palm Skin Perfusion 
16 Forearm Skin Perfusion 
17 Palm Skin Velocity 
18 Forearm Skin Velocity 
19 Palm CMBC 
20 Forearm CMBC 
21 Total Peripheral Resistance 
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 Appendix B: Statistics Code 
 
Example SAS code to calculate 4 factor ANOVA 
 
**************************************************; 
* two within and two between subjects factors; 
**************************************************; 
options ls=200 ps=10000 nonumber nodate; 
data one; 
input id $ y1-y7; 
line + 1; 
gender = ' MEN '; 
if line > 28 then gender = 'WOMEN'; 
protocol = ACTIVE ';  '
if line > 14 then protocol = 'PASSIVE'; 
if line > 28 then protocol = 'ACTIVE '; 
if line > 40 then protocol = 'PASSIVE'; 
day = ' BEFORE'; 
if line > 7 then day = ' AFTER '; 
if line > 14 then day = ' BEFORE'; 
if line > 21 then day = ' AFTER '; 
if line > 28 then day = ' BEFORE'; 
if line > 34 then day = ' AFTER '; 
if line > 40 then day = ' BEFORE'; 
if line > 45 then day = ' AFTER '; 
id_m=substr(id,1,4); 
cards; 
 
DATA GOES HERE. 
 
; 
run; 
 
proc print data=one; 
*var gender day id y1-y7; 
title OLBNP Analysis; 
run; 
 
data two; 
set one; 
seg = '0.010Hz'; y = y1; output; 
seg = '0.020Hz'; y = y2; output; 
seg = '0.040Hz'; y = y3; output; 
seg = '0.080Hz'; y = y4; output; 
seg = '0.100Hz'; y = y5; output; 
seg = '0.125Hz'; y = y6; output; 
seg = '0.150Hz'; y = y7; output; 
run; 
proc means data=two n mean std stderr noprint; 
class gender day protocol seg; 
var y; 
output out=two_means n=n mean=y_mean std=y_sd stderr=y_sem; 
title 'mean responses by each treatment combination'; 
run  ;
proc print data=two_means noobs; 
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where gender ne ' ' and day ne ' ' and protocol ne ' ' and seg ne ' '; 
var gender day protocol seg n y_mean y_sd y_sem; 
run; 
 
proc mixed data=two covtest; 
class gender day protocol seg id_m; 
model y = gender| day| protocol| seg / ddfm = satterth ; 
random id_m(gender*protocol) seg*id_m(gender*protocol)  
        day*id_m(gender*protocol); 
title 'mixed linear model'; 
run; 
 
 
 
 
 
 Appendix C: Mean and Spectral Power Data Results for HUT/LBNP Data 
 
 
 
Table 3: Arterial Pressure Means (mmHg) 
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Table 4: Low Frequency Arterial Pressure Spectral Power (mmHg2) 
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Table 5: High Frequency Arterial Pressure Spectral Power (mmHg2) 
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Table 6: Heart Rate Means (beats per minute) 
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Table 7: Low Frequency Heart Rate Spectral Power (bpm2) 
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Table 8: High Frequency Heart Rate Spectral Power (bpm2) 
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Table 9: Total Peripheral Resistance Means (mmHg/L/min) 
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Table 10: Low Frequency Total Peripheral Resistance Spectral Power (mmHg/L/min)2
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Table 11: High Frequency Total Peripheral Resistance Spectral Power (mmHg/L/min)2
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Table 12: Stroke Volume Means (mL) 
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Table 13: Low Frequency Stroke Volume Spectral Power (mL2) 
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Table 14: High Frequency Stroke Volume Spectral Power (mL2) 
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Table 15: Cardiac Output Means (L/min) 
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Table 16: Low Frequency Cardiac Output Spectral Power (L/min)2
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Table 17: High Frequency Cardiac Output Spectral Power (L/min)2
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Table 18: End Diastolic Volume Means (mL) 
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Table 19: Low Frequency End Diastolic Volume Spectral Power (mL)2
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Table 20: High Frequency End Diastolic Volume Spectral Power (mL)2
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Appendix D: Amplitude and Phase of OLBNP Data 
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 Table 21: Arterial Pressure Amplitudes (mmHg) 
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 Table 22: Arterial Pressure Phase Lags (degrees) 
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 Table 23: Calf Circumference Amplitudes (% change) 
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 Table 24: Calf Circumference Phase Lags (degrees) 
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 Table 25: Heart Rate Amplitudes (beats per minute) 
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 Table 26: Heart Rate Phase Lags (degrees) 
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 Table 27: Total Peripheral Resistance Amplitudes (mmHg/L/min) 
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 Table 28: Total Peripheral Resistance Phase Lags (degrees) 
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 Table 29: Stroke Volume Amplitudes (mL) 
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 Table 30: Stroke Volume Phase Lags (degrees) 
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 Table 31: Cardiac Output Amplitudes (L/min) 
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 Table 32: Cardiac Output Phase Lags (degrees) 
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 Table 33: End Diastolic Volume Amplitudes (mL) 
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Table 34: End Diastolic Volume Phase Lags (degrees) 
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